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Abstract
Drinking during pregnancy can result in fetal alcohol spectrum disorders
(FASD), an umbrella term that encompasses a wide array of symptoms ranging
from neurocognitive deficits to physical malformations. The mechanism for FASD
is not yet fully understood however recently, activation of the neuroimmune
system has been suggested to play a role. Neuroinflammation, characterized by
increased pro-inflammatory cytokine production and glial cell activation, has been
observed following exposure to alcohol during the neonatal period. Furthermore,
neuroimmune activation has been implicated in alcohol-induced neuronal death
and/or damage. The studies herein investigate several components of the
v

relationship

between

neuronal damage following

developmental alcohol

exposure, and neuroimmune system activation.
This dissertation is broken down into two main studies. In the first study,
we focus on the relatively uncharacterized effects of moderate exposure to
alcohol during development. Specifically, re-programming of neuroimmune cells
has been demonstrated following exposure to insult during the neonatal period.
This “primed” neuroimmune system then over-reacts to subsequent insults and
results in exaggerated production of pro-inflammatory molecules, which can
cause behavioral deficits. We hypothesized that exposure to alcohol could elicit
similar effects, and lead to neuroimmune system priming.
In the second study we used a high dose, binge-like exposure paradigm,
during the neonatal period. While this type of exposure has been shown to result
in robust increases in pro-inflammatory cytokine production and microglial
activation,

evidence

for

an

anti-inflammatory

component

also

exists.

Neuroimmune system activation has recently been shown to consist of multiple
pathways, known as M1 and M2. M1 activation is considered pro-inflammatory
and can be neurotoxic,

while M2 is

generally anti-inflammatory and

neuroprotective. This study sought to test the hypothesis that alcohol exposure in
the neonatal period would initially produce a M1-type response followed by a
regenerative M2 period.
The overall findings suggest that high dose, binge-like exposures are
much more disruptive to neuroimmune cells than more moderate, yet longer-term
vi

exposures. This dissertation reports that withdrawal periods may be more
detrimental to neurons than the alcohol exposure itself, and that there is an
important role of astrocytes in mediating this response, that is distinct from
microglia.
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1. Introduction
1.1 Fetal Alcohol Spectrum Disorder Overview
Drinking alcohol during pregnancy is one of the leading causes of
teratogenic birth defects and can result in a child being born with fetal alcohol
spectrum disorder (FASD). FASD is an umbrella term and includes a number of
disorders with symptoms ranging from subtle alterations to debilitating mental
retardation. The most severe form of FASD is fetal alcohol syndrome (FAS),
characterized in part by physical malformations, such as subnormal weight and
height, small eyes, a flattened philtrum, and thin upper lips. In addition, children
with FAS suffer from severe cognitive dysfunction, behavioral abnormalities, and
impaired social skills1. While the incidence of FAS in the U.S. is relatively low, at
approximately 0.1% of live births2, the CDC estimates that the cost of care of
FAS individuals to the U.S. is $4 billion annually. Conversely, FASD is much
more prevalent, occurring in an estimated 2-5% of births in the U.S3, and
includes less severe forms such as Alcohol-Related Neurodevelopmental
Disorder (ARND), which encompasses subtler neurocognitive deficits. Symptoms
of ARND are often similar to those in other developmental conditions, particularly
attention-deficit/hyperactivity disorder,

and as

a

result

ARND is

often

misdiagnosed.
When a pregnant woman drinks, the developing fetus is exposed to levels
of alcohol similar to the mother’s blood alcohol concentration (BAC)4. While the
teratogenic effects of alcohol have been known for decades, and despite public
awareness campaigns including warnings issued by the Surgeon General, 1 in
1

13 women in the U.S. continue to drink while pregnant (CDC). In many instances,
fetal alcohol exposure (FAE) occurs accidentally, since the majority of
pregnancies are unplanned. According to the CDC, 51.5% of women of
childbearing age report drinking alcohol within the last 30 days, and some of
these women could be pregnant and be aware of it. In this case, women typically
abstain from drinking after becoming aware that they are pregnant. As a result,
alcohol consumption limited to the first trimester is the most common pattern of
drinking during pregnancy5. The second most common pattern is drinking
throughout the entire pregnancy, and the third is drinking solely during the third
trimester5 as many women incorrectly believe that the brain and other organs are
fully formed at this point. Additionally, some of these women suffer from
alcoholism and are unable to quit drinking. In this case, their fetuses can be
exposed to very high levels of alcohol. A recent example includes a woman
whose BAC was measured to be 266 mg/dL (3.3 times the legal limit) at the time
that she gave birth4.
Equally worrisome is the amount of misinformation circulating through
magazines, social media, and even by doctors about whether or not drinking
during pregnancy is safe. A number of factors can influence whether or not a
fetus exposed to alcohol will develop FASD, such as the mother’s diet, her
lifestyle and stress levels, genetics, co-exposure to other drugs, and the mother’s
body weight and metabolism, which determine her resulting BAC after each drink
and the rate at which it is cleared6,7. Therefore, it is possible that if two pregnant
women consume the same amount of alcohol, one could have a child with FASD
2

and the other a child who is unaffected. As a result, there is considerable
disagreement between even medical professionals about whether or not drinking
low levels of alcohol during pregnancy is dangerous.
There exists little in the way of treatment options for FASD patients and
almost all are based on behavioral, educational, or social interventions2. Some of
the most promising potential therapeutics includes enriched environments, which
has been shown to improve neurogenesis in animal models of FASD.
Additionally, nutritional supplementation with choline has been shown to improve
some behavioral outcomes8. At present, no medications have been approved
specifically to treat FASD.

1.2 Animal Models of FASD
To investigate the mechanism for how FAE negatively affects brain
development and to develop potential therapeutic options, animal models are
typically utilized to study this disorder. Rodents, either mice or rats, are the most
common type of animal used in FASD research, however rodents do not willingly
ingest significant levels of alcohol. Instead there are several ways to administer
alcohol to rodents. Some of the most prevalent are via oral gavage into the
stomach, an intraperitoneal (i.p.) injection, mixing the alcohol into food or
sweetened water, or vapor inhalation. Each method has accompanying
advantages and disadvantages.
Mixing the alcohol into the animal’s food or water source is typically
considered lower stress than other methods, and alcohol is ingested similarly to
3

normal human consumption. This method has several limitations in that it is
difficult to control dosage and often cannot be used to achieve high BACs, in
part, because alcohol has an aversive taste to rodents. Conversely, alcohol
administration via I.P. injection or gavage can be used to reach high BACs and
offer more control over dosing. Unfortunately, these methods are very stressful
for the animals and result in an unrealistically sharp rise in BACs that peak within
30 minutes9. Finally, vaporizing the alcohol so it can be inhaled has the
advantage of reducing animal handling and, in the case of postnatal exposure,
allows pups to remain with their mothers. BACs rise more gradually than in
gavage and I.P., and high BACs can be achieved this way. However, in
inhalation, the alcohol bypasses the first pass metabolism that would normally
take place in the liver and stomach, in which the enzyme alcohol dehydrogenase
breaks alcohol down into acetaldehyde10. Instead, the alcohol enters the
bloodstream through the lungs, making it a less realistic administration model.
Additionally, the intense smell of the vaporized alcohol likely introduces an
alternative form of stress.
Another consideration when using rodent models is in the differences
between the rodent and human gestational periods. Specifically, the rodent
gestational period comprises only the stages of development that would take
place in a human pregnancy during the first and second trimester. The third
trimester-equivalent occurs during the first two postnatal weeks in a rat pup11. As
a result, FASD research has typically focused on either alcohol exposure during
the first and second trimesters (prenatal) or the third trimester (postnatal), but not
4

in all three. Studies in prenatal and postnatal models can often show different
outcomes, highlighting the heavy influence the timing of exposure has on the
effects seen in both rodents and humans. For example, early postnatal ages in
rodents may be particularly sensitive to neurocognitive damage as the third
trimester-equivalent is when many important processes of central nervous
system (CNS) development occur, including synaptogenesis; a period known as
the brain growth spurt11.
Lastly, along with the factors listed above, dose and pattern of exposure
are two of the most important elements of an exposure paradigm. There are
many different patterns of normal human alcohol consumption. While binge
exposures more realistically model types of drinking observed in college-age
women and alcoholics, moderate and low dose exposures are more reflective of
women with a higher socio-economic status12. As stated above, there is no safe
level of alcohol during pregnancy and studies utilizing low or moderate alcohol
doses have found a number of negative consequences, which will be reviewed in
greater depth in the following sections. However, binge alcohol exposure is
widely accepted as the most harmful type of fetal exposure13-15. The NIAAA
defines binge exposure as a pattern of drinking that induces BACs above the
legal limit of intoxication within 2 hours (0.08 g/dL, around 4 drinks in an average
woman). Importantly, to mimic this type of exposure in rodents it may be
necessary to use even higher BACs, as rodents have been shown to be more
resistant to alcohol than humans16,17, in part due to their elevated metabolic rate.
It is critical that studies continue to investigate the array of effects generated by
5

different doses and patterns of drinking, as ideally future FASD treatments will
consider these factors on an individual patient basis in order to prescribe the
most efficacious treatment option.
To sum, there are many important aspects to consider when designing an
FASD paradigm in an animal model, emphasizing the complexity of this disorder.
While it is essential that the individual effects of each factor be assessed,
differences in exposure paradigms can lead to contrasting results and make it
difficult to compare conclusions reached across studies. In the next sections,
findings from different FASD models will be discussed with regard to the
hippocampus and cerebellum; two brain regions that have been shown to be
particularly susceptible to insult by FAE.

1.3 The Hippocampus: Function, Anatomy and Development
The hippocampal formation is part of the limbic system and is responsible
for many important CNS functions, most notably learning and memory. The
structure is divided into sub regions, consisting of the dentate gyrus (DG) and the
Cornu Ammonis (CA) areas, which are considered the hippocampus proper and
of which the CA1 and the CA3 are the best characterized18. The primary cell type
of the DG and the CA sub regions are the granule cells and pyramidal neurons,
respectively, which are both excitatory and organized into distinct layers. There is
also a highly diverse population of GABAergic interneurons throughout the
hippocampal formation, including the axo-axonic cells, basket cells, and orienslacunosum moleculare cells18.
6

The major input to the hippocampus comes from layer 2 of the entorhinal
cortex (EC), which projects primarily into the DG, along the perforant path. The
granule cells then relay this information through the mossy fiber pathway, which
synapses onto the CA3 pyramidal neurons18. From the CA3, information flows to
the CA1 pyramidal neurons along the Schaffer collateral pathway. This DG-CA3CA1 loop is known as the tri-synaptic circuit (Figure 1.1). Importantly, the CA3
pyramidal cells also receive a high amount of input/output from neighboring cells,
as this region is highly interconnected by the associational-commissural (AC)
pathway19. CA1 neurons are the major output for the hippocampus and project
back out to the EC, which is then relayed to other parts of the cortex. The
hippocampus also has additional output pathways to the fornix and the
amygdala20.

Figure 1.1: Structural Organization of the Hippocampus

7

Neurogenesis occurs in waves in the hippocampus, beginning as early as
embryonic day (E)10 and continuing into the postnatal period19 (and adulthood in
the DG). In the CA3, neuronal birth peaks at E14 while in the CA1 it is most
pronounced slightly later at E15. In the DG neurogenesis occurs over a longer
timescale, peaking at E16 and continuing until the first postnatal week in the DG.
Within a couple of days after their birth, neurons begin migrating to their
respective cell layers, guided by glial cells. Synaptogenesis occurs primarily
during the 3rd trimester-equivalent of development along with synaptic pruning,
although refinement of synapses can continue into adolescence. Importantly,
these stages of development can occur on slightly different timescales in the
individual sub regions19. However, recent studies have discovered massive
increases in cell number from postnatal day (P)3-7, followed by a period of cell
loss, throughout many regions of the brain including the hippocampus21. These
findings are at odds with others in the literature, and suggest that neurogenesis
and gliogenesis transpire heavily in the rodent postnatal period and that the
majority of cells in the brain are generated during this time. The important
functions of the hippocampus, combined with its noteworthy configuration and
unique characteristics have made this one of the most studied regions of the
brain, including in the pathophysiology of FASDs.

1.4 The Hippocampus and FASD
It is well established that fetal exposure to alcohol can result in deficits in
hippocampal-dependent behavior. There exist several behavioral paradigms to
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assess hippocampal function, including the Morris Water Maze (MWM),
variations of fear conditioning paradigms, and the radial arm maze, each of which
are tests of the rodent’s learning and memory abilities. The MWM, a measure of
spatial memory, is one of the best characterized with respect to developmental
alcohol exposure and deficits have been observed in both pre- and postnatal
models22-25, as well as in human FAS subjects when tested on a virtual version of
this task26. Similarly, FAE has been shown to impair performance on variations of
the fear conditioning task and/or the radial arm maze27-30.
The hippocampus is a site of considerable neuronal plasticity and the only
brain region in humans that undergoes neurogenesis in adulthood. FAE can
interfere with these processes, which have been linked to the deficits in learning
and memory described above31. Developmental alcohol exposure has been
shown to affect synaptic transmission and plasticity, although the mechanism
likely differs between prenatal and postnatal models.

In prenatal exposure

models, NMDA receptors seem to be particularly sensitive to insult. One study
found reduced neuronal plasticity and changes in NMDA receptor subunit
composition in the DG32. A comparable alcohol exposure model impaired
NMDAR activation of ERK signaling, also in the DG33. Finally, prenatal alcohol
decreased NMDA receptor binding sites, in multiple sub regions of the
hippocampus, into adolescence34.
Similarly, postnatal alcohol exposure has been shown to inhibit synaptic
plasticity in the CA135 and CA3 sub regions36. However, an acute application of
alcohol to neonatal slices suggested that, at this age, alcohol interferes with
9

hippocampal transmission through inhibition of presynaptic voltage-gated Ca2+
channels and affects both AMPA and NMDA receptors37. In this study, the
authors suggest that differences in the receptor subunits expressed during
development, and the phosphorylation states, could explain the increased
sensitivity to alcohol at this time.
FAE has also been shown to interfere with neurogenesis31. The
generation of adult-born neurons occurs specifically within the DG and is thought
to be the basis of new memory formation, as increases in neurogenesis correlate
with learning, as well as with improved performance on some learning and
memory tasks. However, exactly how neurogenesis contributes to memory
formation is not fully understood, and the concept remains controversial38. A
model of postnatal binge exposure reduced the survival of adult born neurons
and prevented incorporation into the neuronal network39. Similarly, exposure to
moderate levels of alcohol during the prenatal period has been shown to blunt
the normal neurogenic response to an enriched environment40 and alter the
expression of genes involved in neurogenesis41.
Finally, one of the most detrimental effects of postnatal alcohol exposure
is neuronal loss, which is seen in the hippocampus after high dose, binge
exposures encompassing periods late in the first postnatal week13,42,43.
Importantly, when exposure is limited to early in the postnatal week (~P3-4), no
cell loss is observed44,45, suggesting that there is a specific window of
development during which the hippocampus is susceptible to neuronal loss.

10

1.5 The Cerebellum: Function, Anatomy and Development
The cerebellum is best characterized for its motor functions46,47, in which it
is critical for maintaining balance, motor learning, and coordinating voluntary
movements. Additionally, several human studies have suggested the cerebellum
has a role in a number of other neurocognitive processes, such as emotion

48,49

memory retrieval50, and attention51. It has also been theorized to play a role in
psychiatric disorders52.
Structurally, the cerebellum consists of two hemispheres, divided by a
mid-line region known as the vermis52. The cerebellum is further organized into
distinct lobules that increase in number toward the midline and in the adult
vermis there are 10 lobules. Importantly, in the developing brain the lobules
mature at different rates53.
The principal neuron of the cerebellum is the Purkinje cell (PC)54. Their
axons provide the sole output from the cerebellar cortex and project to the deep
cerebellar nuclei. From the deep cerebellar nuclei information is relayed to target
regions (e.g., cortical and spinal motor neurons) via brainstem and thalamic
neurons. PCs are GABAergic neurons, though there exist a number of other
inhibitory interneurons in the cerebellum, such as the Golgi, stellate and basket
cells. PCs receive inhibitory input from other PCs through the recurrent
collaterals, and from the surrounding interneurons. The major excitatory cell type
in the cerebellar cortex is the granule cell, which projects to PCs via the parallel
fibers. Excitatory input also comes from inferior olive neurons (climbing fibers),
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which synapse onto the PCs, and the precerebellar nuclei (mossy fiber pathway)
which provides input to granule cells. While granule cells are some of the
smallest neurons in the brain, PCs are some of the largest54. The cellular
structure of the cerebellum is well organized into specific layers. In the adult, the
outermost layer is the molecular layer, which contains the parallel fibers and
stellate cells. The next is the PC layer (PCL), which contains the PC soma. The
innermost layer is the granule cell layer which houses the granule cells and Golgi
cells55.

Figure 1.2: Structural Organization of the Cerebellum.
Reproduced from NEUROSCIENCE, Fourth Edition, Figure 19.10 (Part 1)

During development, PCs of the cerebellum are generated around E1013, while granule cell precursors emerge from E12-17, before migrating along
glial cells to their respective layers. Initially, granule cells make their way to the
external granule layer (EGL) which is a temporary cell layer consisting of
proliferating neurons. During the postnatal period, cells in this layer migrate
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through the PCL and into the internal granule layer (IGL), which is equivalent to
the granule cell layer in the mature brain. In the late postnatal period, and for a
few weeks following, there is a period of programmed cell death in which the total
number of cerebellar neurons is diminished. During the postnatal period is also
when the majority of interneurons are generated56 and large increases in the
number of neuronal and non-neuronal cells continues to occur during the first
postnatal months21. During the 3rd trimester-equivalent the neuronal network is
established in the cerebellum, including refinement of climbing fiber synapses57
and formation of the mossy fiber pathway58.

1.6 The Cerebellum and FASD
A number of behavioral tests can be used to assess cerebellar function.
Some of the most common include the runway assay, which measures
alterations in gait, and the rotarod, which is a measure of balance and motor
coordination. Another common test is called eyeblink conditioning, in which the
subject receives a conditioned stimulus, such as an auditory tone, before a puff
of air is released into their eye. Eventually the subject will adopt a conditioned
response and blink in response to the conditioned stimuli, before the puff occurs,
the development of which has been shown to be cerebellar-dependent59.
Prenatal alcohol exposure has been shown to result in deficits in all three tests60.
Similarly, exposure to alcohol during the 3rd trimester-equivalent has been shown
to impair performance in all of the tests listed above, and some additional
cerebellar-dependent tasks61-64.
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There are several potential mechanisms by which FAE may be
contributing to these functional deficits. First, FAE has been shown to interfere
with several components of cerebellar maturation. When rat pups were exposed
to alcohol through gestation and weaning, the migration of granule cells was
delayed and they exhibited an enlarged cellular morphology. Additionally, in that
study Bergmann glia exhibited structural alterations indicative of immaturity,
which may explain the obstructed granule cell migration as the glia are important
for providing guidance during this process65. Similarly, a single injection of
alcohol in the postnatal period (P10) was enough to inhibit granule cell migration,
potentially by interfering with signaling pathways66. Furthermore, postnatal
alcohol exposure decreased synaptogenesis in the cerebellum67.
Second, FAE may be affecting synaptic plasticity and transmission. In a
prenatal model, Servais and colleagues found that alcohol decreased the voltage
gated calcium currents in PCs and led to increased firing. Furthermore, parallel
fiber synaptic plasticity, was switched to from long-term depression (LTD) to
long-term potentiation (LTP). They were able to link these changes to deficits in
cerebellar-dependent behavior60.
A third mechanism for FAE-induced deficits in cerebellar function is cell
loss. As in the hippocampus, neurodegeneration can occur after exposure to
alcohol during the postnatal period68. However, while hippocampal cell loss is
seen only after alcohol exposure late in the first postnatal week (P7-9), the
window of development in which the cerebellum is most vulnerable is
comparatively earlier (~P4)69-73 although exposure throughout all three trimesters
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worsens this effect74. Additionally, the lobules themselves exhibit diverse
susceptibilities, with the earlier maturing lobules (I-III and IX-X) showing
increased neuronal loss after postnatal alcohol exposure53. Interestingly, 3rd
trimester-equivalent exposure can also cause neuronal loss in the deep
cerebellar nuclei, which receives output directly from PCs62.
While the mechanism is not fully understood for how FAE damages the
cerebellum and hippocampus, particularly with respect to neuronal loss, recently
activation of the neuroimmune system has been suggested to play a role. The
following sections will address this possibility.

1.7 Neuroimmune Sytem Overview
The nervous system is isolated from the rest of the body by the blood
brain barrier (BBB), an additional lining around the blood vessels that prevents
passage of hydrophilic or large molecules into the parenchyma. The innermost
layer of the BBB consists of closely packed endothelial cells interfacing at tight
junctions. The next layer is an extracellular matrix known as the basal lamina.
Outermost are the feet of astrocytes, which provide further structural support.
Pericytes, microglia, and perivascular macrophages can also contribute to BBB
integrity. The BBB is a selectively permeable barrier; small gaseous molecules
and lipophilic substances (such as ethanol) can diffuse across. Additionally, there
are selective transport mechanisms to allow passage of certain nutrients.
However, the entry of hydrophilic and/or large molecules is restricted, as well as
the migration of cells of the peripheral immune system75. As a result, the brain
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has its own highly specialized immune system, known as the neuroimmune
system, which protects the CNS.
Although the brain has traditionally been thought of as immunoprivileged,
it is important to note that recent studies are finding more and more that there is
an intense interaction and interconnection between cells of the nervous system
and the peripheral immune system. For example, neurons can regulate
peripheral innate immune responses through secretion of soluble factors or even
direct interaction with peripheral immune cells76. Furthermore, very recent
research has identified a novel lymphatic system that allows passage of
peripheral immune cells into the CNS77, which could potentially implicate these
cells in many CNS processes.

1.8 Cells of the Neuroimmune system
The best-characterized cells with respect to the neuroimmune system are
microglia, which are the resident macrophage of the CNS. Microglia were first
described in 1932 by Pio del Rio-Hortega. Under normal conditions, he noted
that microglia have small cell bodies and long dendritic processes, a morphology
that has been termed “resting” as the cell bodies do not move around freely78.
However, strong evidence has proven that microglia in a “resting” morphology
are anything but that, with their processes constantly surveying the environment
and making contact with nearby cells79. A number of cues, including changes in
their surrounding environment, can cause the microglia to rapidly change their
phenotype, which is often accompanied by a morphological change80. This
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morphological change occurs along a spectrum, as the microglia distend their
processes and their cell body swells. At the far-end of this spectrum the microglia
exist in what is called an “amoeboid” morphology or, until recently an “activated”
morphology, as microglia in this state have been shown to release molecules that
can be neurotoxic and exhibit phagocytic activity81. However, there is now
mounting evidence to show that changes in microglia morphology, while a good
marker, are not always indicative of phenotype or activity80.
A number of new roles for microglia have been discovered, changing the
viewpoint on the importance of these cells in the CNS, and will be discussed in
more depth in later sections. Briefly, rather than being strictly neuroinflammatory
cells, microglia have recently been shown to have important functions in
homeostasis and during development. Additionally, one of the most controversial
and highly debated subjects with respect to microglia pertains to a potential role
in mediating toxicity in cases of neurodegeneration.
Another important cell type of the neuroimmune system is the astrocyte.
Astrocytes are star-shaped glial cells with many important functions in the CNS,
including providing structural support to the BBB as previously mentioned. In
response to CNS insult, astrocytes assume a structural change that includes
thickening of their processes. These “reactive” astrocytes mediate astrogliosis, or
“reactive gliosis” (proliferation of astrocytes), and up-regulate intermediate
filament proteins, in particular glial fibrillary acidic protein (GFAP). This elevated
GFAP production is highly associated with increased gene expression and an
“activated” phenotype82. Astrocytes are thought to communicate largely through
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calcium waves, which can be transmitted to other cells across gap junctions or by
the release of gliotransmitters, such as ATP, and represent a potential for rapid
communication with distant astrocytes83.
While microglia and astrocytes are the primary cells of the neuroimmune
system, there exist a host of other cells that can play a role in mediating this
response. A great deal of communication occurs between neurons and glia cells,
and neurons can guide many of their responses (as discussed in the next
section). Additionally, some peripheral immune cells (mostly T cells) exist within
the healthy brain at low levels and contribute to surveillance84. Under
inflammatory conditions, peripheral cells infiltrate the brain and assist in
defending the CNS.

1.9 Neuroimmune Signaling
1.9.1 Neuronal-Glial Communication
There is a great deal of neuroimmune signaling that occurs between the
cells of the neuroimmune system under both resting and pathological conditions,
and the activation of each cell is tightly regulated by this network. Neurons
interact closely with glial cells at multipartite synapses and have been shown to
regulate neuroinflammation a number of different ways. One of the well-studied
mechanisms is through the constitutive expression of the chemokine, fractalkine,
whose receptor is expressed primarily on microglia. Fractalkine has an important
role in chemotaxis. It was initially thought of as recruiting and activating microglia,
although more recent studies have shown that fractalkine likely restricts
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microglial activation in the healthy brain85,86. Similarly, glial cells express
receptors for a multitude of other substances released from neuronal terminals
such as substance P, neurotransmitters, and ATP78,87,88. Glutamate, GABA, and
ATP were all shown to increase superoxide production in cultured microglia,
although phenotype varied based on the stimulant 89. Histamine and substance P
were also found to increase microglial production of pro inflammatory cytokines
and ROS generation90. Interestingly, it has been suggested that specific subsets
of microglial populations have different sensitivities to these molecules91. Finally,
microglia can respond to episodes of increased neuronal firing, through an ATPdependent mechanism92, suggesting that neuroimmune responses could be
activity-dependent.
Neurons can also heavily influence surrounding astrocytes. In one
experiment, stimulation of the Schaffer collateral pathway in the hippocampus
induced intracellular calcium increases in astrocytes93. The authors further
demonstrated that this effect was likely mediated by glutamate, released from
neuronal terminals, binding to metabotropic glutamate receptors on nearby
astrocytes. Indeed, increased calcium signaling in astrocytes in response to
neuronal activity or neurotransmitters has been widely observed94-96, and
blocking astrocytic calcium signaling has been shown to interfere with types of
neuronal transmission and plasticity97-99. These findings suggest that neuronastrocyte intercommunication is essential for normal brain function, yet the
implications of astrocytic calcium waves are still controversial100. Both microglia
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and astrocytes can also influence neurons, and each other, through secreted
factors such as cytokines, which will be discussed more in the next section.

1.9.2 Cytokine Secretion
Cytokines are small, protein signaling molecules that can have autocrine,
paracrine, or some times endocrine effects. In the CNS, they are produced by
neurons and glial cells101, however they can also be sourced from peripheral
immune cells and cross the BBB. Most cytokines are produced in their proform
and must be cleaved into an activated state before binding to their receptor102.
While cytokines were originally characterized as being immune modulators, they
have since been shown to play important roles in many other biological
processes and are commonly considered neuroimmune signaling molecules.
Receptors for a multitude of cytokines are constitutively expressed on both glial
cells and neurons102, although receptor expression is also inducible under
pathological conditions103,104. Cytokines are typically classified as being either
pro- or anti-inflammatory depending on their effects, however many cytokines
can elicit dual functions.
Two of the best-characterized pro-inflammatory cytokines in the CNS are
tumor necrosis factor α (TNFα) and interleukin 1β (IL1β). TNFα is a member of
the TNF superfamily of ligands and can be produced by glial cells and certain
neurons. It has two receptors, TNF receptor 1 (TNFR1) and TNF receptor 2
(TNFR2). In the brain, TNFR1 is expressed in most cells including astrocytes,
microglia, neurons, and oligodendrocytes105,106, whereas TNFR2 is primarily
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expressed in microglia and other immune cells107,108. Ligand binding to the two
receptors has been shown to have differential outcomes. Activation of TNFR1 is
generally cytotoxic, while TNFR2 has been shown to be neuroprotective in some
cases109,110.
TNFR1 works as a signaling complex with TNF receptor associated death
domain and other adaptor proteins, such as receptor interacting protein and TNF
receptor associated factor 2107. Binding to TNFR1 can lead to activation of a
number of pathways, including ERK, JNK, and p38 MAP kinase, and activation of
transcription factors such as NF-kB. Additionally, in some cases TNFR1 is
internalized after TNF binding, at which point it can trigger apoptosis by
association of Fas-associated death domain, activation of caspases, and
formation of the death-inducing signaling complex. As a result, TNF signaling
through TNFR1 can have a variety of outcomes, including proliferation and/or
activation that likely depend on environmental factors and on in which cell type
the receptor is expressed107.
TNFR2 signaling shares some similarities to TNFR1; signaling through
this receptor involves TRAF2 and can lead to increased transcription by NF-kB.
However, TNFR2 does not have a death domain. Additionally, TNFR2 is
preferentially activated by membrane-integrated TNF, rather than the soluble
form, whereas TNFR1 is activated by both forms. Interestingly, there is some
evidence to suggest that the TNFR1 and TNFR2 receptors have a degree of
crosstalk that influences signaling outcomes, further diversifying the types of
responses generated by TNF binding111.
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Conversely, IL-1β, one of the most important pro-inflammatory cytokines,
primarily binds to one receptor, the IL1 receptor type I (IL-1R1), although there is
a type 2 II1 receptor that is thought to act as a decoy. IL-1R1 has differential
expression levels throughout the brain, with some of its highest densities being in
the granular layer of the DG and granule cell layer of the cerebellum. It is
primarily expressed in non-neuronal cells, but there is evidence to suggest that it
is expressed in neurons as well112. Activation of IL-1R1 in neurons has been
implicated in both neuronal survival and death113,114. IL-1R1 is dependent on
myeloid differentiation primary-response protein 88 (MYD88) and acts through
recruitment of interleukin-1 receptor-associated kinases (IRAKs). In some cases,
binding to IL-1R1 leads to NF-kB activation, and in others it acts through the p38
or MAPK pathways. IL-1β elicits different responses in different cell types, likely
because of different IL-1R1 signaling pathways becoming activated. One cell
culture study showed that the IL-1R1 signaling pathway that became activated
after ligand binding was different in neurons than in glial cells115.
There are also anti-inflammatory cytokines which can mediate glial cell
activation and inhibit the release of pro-inflammatory cytokines116. Two common
anti-inflammatory cytokines are transforming growth factor beta (TGFβ) and
interleukin 10 (IL-10). TGFβ is produced by many cell types, including glial cells
and neurons117,118. There exist three isoforms of TGFβ (1, 2, 3) and two of its
receptors (type I and type II). TGFβ receptor signaling is mediated either by
SMAD proteins, which can act as transcription factors and regulate gene
expression119, or by activating anti-apoptotic NF-kB pathways120. In neurons,
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TGFβ is important for cell survival121 and was recently found to act as a “switch”
critical for neurogenesis122.
IL-10 is a powerful anti-inflammatory cytokine that is being investigated as
a potential therapeutic for many inflammatory diseases123-125. Astrocytes and
microglia both express IL-10 receptor and produce IL-10126. IL-10 receptor
signaling in immune cells has been shown to be mediated by the JAK-STAT
pathway127. The role for IL-10 and its receptor is more controversial in neurons,
though IL-10 has been shown to have important roles in neuronal survival. In a
cell culture model, the IL-10 receptor was found to be expressed on spinal
neurons and directly contributed to cell survival128. However, a similar study
showed IL-10 signaling was mediated in neurons by PI3K and STAT-3
pathways129. To my knowledge, IL-10 receptor expression has not yet been
confirmed in neurons in-vivo.

1.10 Neuroimmune Functions in Inflammation
A number of different stimuli can generate neuroinflammation including
invasion of pathogens or harmful molecules, excitotoxicity, debris from dead
neurons, and brain trauma. The type of response generated depends heavily on
the insult, factors in the environment, and interactions between the cells involved.
Typically, neuroinflammation is characterized by increased cytokine production,
production of reactive oxygen species (ROS) and other molecules, and
morphological/phenotypic changes in glial cells.
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Microglial activation is being discovered to be a complex and controversial
subject. We understand that microglial activation is a “rolling” or graded
process130 that can differ depending on the situation or insult. Microglia can
become only partially activated or they can become fully amoeboid, a state that is
classified by the microglial cell body becoming mobile and by phagocytic activity.
Phagocytosis by microglia is critical for helping clean up debris and dead
neurons. However, in some cases it has been shown that microglia can also kill
viable neurons by phagocytosing them131.
Recently, the discovery of M1 and M2 activation has introduced another
element into microglial activation. First described in macrophages, recent studies
have identified that microglia also express different phenotypes of activation132.
The M1 phenotype designates an activated state in microglia that is heavily proinflammatory and, when prolonged, neurotoxic. Conversely, M2 activation is
considered anti-inflammatory and neuroprotective.

Even beyond that, M2

activation is being broken down into further subsets including M2a (antiinflammatory, alternative activation) and M2b/c (deactivation/wound healing and
repair), which are classified by distinct markers and cytokines133,134. Due to the
cytotoxic effects of prolonged M1 neuroinflammation, blocking neuroimmune
activation has long been considered as a potential therapeutic intervention
against a number of diseases. However, the discovery of distinct functions for
these two types of activation, with M2 having many beneficial functions in
regeneration135,136, has led to some focus on attempting to alter the polarization
of microglia (M1->M2), rather than blunting activation altogether.
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Like

microglia,

astrocytes

have

their

own

unique

roles

in

neuroinflammation. In the case of severe CNS injury, such as lesions, astrocytes
react by walling off the affected area and forming a glial scar. This barrier
consists primarily of reactive astrocytes and is critical for stopping the spread of
inflammation and in neural repair137. However, astrocytic scars can also prevent
axon regeneration, and recent attention has focused on ways to circumvent this
obstruction138.
While the orchestration of neuroimmune responses has typically been
attributed to microglia, astrocytes have been shown to regulate microglial
activation and to have their own independent functions139,140. This suggests that
astrocytes may have a prominent role in directing neuroinflammation.
Additionally, like microglia, astrocytes can be either pro- or anti-inflammatory,
depending on the situation and type of insult137.
Finally, in certain inflammatory conditions, peripheral immune cells are
recruited across the BBB to aid in the neuroinflammatory response141,142.
Chemokines, a type of chemotactic cytokine involved in immune cell recruitment,
are particularly important to this process. Chemokines work by binding to G
protein-coupled receptors and inducing chemotaxis. Furthermore, chemokine
secretion can up-regulate integrins and adhesion molecules, such as ICAM and
VCAM, on the endothelial cells of the BBB. These integrins bind to the immune
cells and arrest their movement, allowing them to squeeze between the tight
junctions of the endothelial cells and into the perivascular space. Beyond that,
these cells likely traverse the barrier formed by the astrocyte end feet (glia
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limitans) in a manner dependent on matrix metalloproteases141,142. Inflammation
can also lead to BBB breakdown and less closely associated endothelial cells,
which increases permeability and allows peripheral cells to infiltrate the CNS
more easily, although the mechanism is not completely understood143. After the
inflammation resolves it is thought that many of the peripheral cells die144,
although there is some evidence that macrophages in the brain will differentiate
into resident microglia145.

1.11 Neuroimmune Functions in Homeostasis
Under normal conditions, microglia and astrocytes have many important
roles in maintaining homeostasis. Astrocytes are well known for their function in
providing neuronal support, particularly in removing excess neurotransmitter from
the synaptic cleft to maintain neuronal excitability while preventing excitotoxicity.
They are also thought to provide energy by taking up glucose, producing lactate,
and shuttling it to neurons. They have many neuroprotective functions, including
providing neurons with precursors for the powerful antioxidant and ROS
scavenger, glutathione146. Under neuroinflammatory conditions, when astrocytes
become reactive, they reduce some of these support processes147. Finally,
astrocytes are important players in mediating synaptic plasticity148.
Microglia also provide support for neurons149 and regulate synaptic density
and function150. In addition, microglia stimulate learning-related synapse
formation by secretion of brain-derived neurotrophic factor (BDNF)
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151

and may

also promote synapse formation through the release of IL-10152. Finally, there is
evidence that microglia control synaptic strength153,154.
Similarly, cytokines have been shown to regulate synaptic plasticity and
transmission. In one study, deleting the TNFR1 in neurons reduced the number
of synaptic AMPA receptors and inhibited transmission108. Similarly, increasing
the levels of pro-inflammatory cytokines has been shown to affect synaptic
transmission.

Increasing

IL-6

enhanced

synaptic

transmission

in

the

hippocampus, but reduced some forms of plasticity in an age-dependent
manner155. Similarly, application of pro-inflammatory chemokine CCL2 increased
synaptic currents and neuronal firing in the hippocampus156, while increased IL1β blocks BDNF-dependent long-term plasticity in the same region157.
Interestingly, IL-1R expression is densest at synapses and IL-1R interacts with
NMDA receptors, indicating a potential role for IL-1β in modulating NMDA
receptor function158.

1.12 Neuroimmune Functions during CNS Development
Many important CNS developmental processes occur during the third
trimester-equivalent to human pregnancy. This is the period in which
synaptogenesis, network formation, and potentially even neurogenesis, transpire.
Additionally, the majority of gliogenesis and glial cell maturation takes place,
concurrent with these processes.
Microglial precursors originate from the bone marrow, however the
process of entry into the brain as monocytes and eventual differentiation is
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controversial. Fate mapping studies suggest that CNS infiltration of the microglial
progenitors occurs in waves at different developmental time points, with the first
wave of hematopoiesis into the CNS occurring between E7-7.5 from the extraembryonic yolk sac159. Specifically, microglial progenitors are detected in the
cerebellum as early as E11160. Interestingly, one study showed that when
microglia were depleted form the adult brain, the microglial population was
replenished within 1 week, likely by microglial progenitor cells residing in the
CNS161.
During the postnatal period, microglial proliferation peaks162 and microglia
begin to mature. However, during the early postnatal period microglia are in an
immature state that resembles the amoeboid morphology associated with
activation in adulthood. It is during the first two weeks of postnatal life in rodents
that microglia adopt the ramified morphology seen under normal conditions in
adulthood163. Interestingly, microglial maturation has been shown to be brain
region- and sex-dependent. Males have more microglia during the early postnatal
period than females, while females have more amoeboid microglia in
adolescence and as young adults164. Furthermore, there is evidence to suggest
that microglia interact with the nervous and endocrine systems during
development to “masculinize” the brain, contributing to sex differences in
behavior165. Additionally, microglial maturation has been shown to occur on a
slightly delayed timescale in the cerebellum than hippocampus166.
Like most cells of the CNS, astrocytes differentiate from neural stem cells
and are thought to arise initially from progenitors in the subventricular zone167.
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During the first few weeks of postnatal life, there is a period of massive
gliogenesis, in which the population of astrocytes increases by 6-8 fold. Recent
studies have shown that the majority of cortical astrocytes likely arise from this
local gliogenesis, rather than infiltrating cells168. However, astrocyte gliogenesis
occurs in other brain regions from E17 or earlier. Similar to microglia, astrocytes
also mature during the postnatal period, adopting their long, fine processes and
beginning to express genes important for proper functioning, including in
neuronal support169.
Despite the fact that these cells are undergoing their own maturation
during this time, both microglia and astrocytes have important functions in CNS
development. Recently, microglia were shown to be critical for synaptic pruning
during development, actively engulfing and removing unnecessary synapses
thereby fine-tuning neuronal networks170. Additionally, astrocyte regulation of
glutamatergic signaling, including removal of glutamate from synapses, is critical
for proper neurite outgrowth, neuronal migration, and synaptogenesis169.
Cytokine secretion also plays an important role in development. Cytokines
have been shown to exist at different levels in the postnatal brain than in adults,
suggesting an important role in development, and occurring in a sex-specific
manner132. Specifically, cytokines and chemokines have important roles in
neuronal differentiation, successful migration of progenitors, and synaptic
strength and refinement171.
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Given these important roles, it is not surprising that dysfunction of the
neuroimmune system has been implicated in a number of neurodevelopmental
disorders. Increased astrogliosis has been observed in the brains of autism
patients172. Additionally, neurons had stunted dendritic outgrowth when cocultured with astrocytes derived from a rodent model of Rett syndrome,
suggesting that improper functioning of these astrocytes contributes to this
disorder169. Similarly, compelling research implicates early-life infection and
subsequent microglial activation in the development of schizophrenia173.
Furthermore, anti-psychotic drugs were shown to decrease neuroinflammation174,
suggesting that reduction of neuroimmune responses may alleviate some of
these symptoms.
Finally, seminal work by Dr. Bilbo’s lab has shown that developmental
insults that activate the neuroimmune system (such as infections) can lead to
subtle yet long-term changes in microglia that alters their programming into
adulthood. These “primed” microglia appear normal, but over-react to secondary
insults in adulthood, resulting in exaggerated cytokine production and secretion,
and contributing to behavioral deficits163.

1.13 The Neuroimmune System and Alcohol
A number of studies have provided evidence for a central role of the
neuroimmune system in mediating alcohol’s effects on the brain, particularly in
adults. Post-mortem analysis of adult alcoholics revealed brain-region specific
increases in the microglial marker, ionized calcium-binding adaptor molecule 1
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(IBA-1), indicating that microglia are activated and/or increased in number.
Additionally,

expression

of

the

pro-inflammatory

chemokine

monocyte

chemoattractant protein-1 (MCP-1, also known as CCL2) was elevated175. These
findings were confirmed in a rodent model, in which long-term alcohol use
elevated MCP-1 expression and microglial activation, and the effects were
correlated with impairment of spatial memory and increased BBB permeability176.
Acute alcohol was also shown to change the expression of hundreds of proteins,
some involved in the neuroimmune system, when applied to cultured
microglia177. Similarly, when alcohol was applied to cultured astrocytes,
increased NF-kB nuclear translocation was observed178 and there was increased
production of pro-inflammatory iNOS, COX-2 and IL1β179. Finally, binge-alcohol
exposure has been shown to cause neuronal death in parallel with large-scale
activation of microglia and astrocytes180, suggesting there may be a relationship
between glial cells and neuronal loss. However, Marshall and colleagues utilized
a model of heavy binge exposure, that was previously shown to result in
neuronal loss, and called into question some of these previous findings. In this
study they found increased microglial activation, but no evidence of proinflammatory cytokine production or BBB breakdown. Instead they found small
increases in anti-inflammatory IL10 and TGFβ, suggesting that there may be a
contribution of M2-type activation in alcohol-induced neuroimmune responses181.
In adults, alcohol exposure has been suggested to modify neuroimmune
cell programming, similar to priming in neonates, altering the way they react to
additional insults. Pre-exposure to alcohol resulted in exaggerated production of
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pro-inflammatory

cytokines

and

microglial

activation

after

injections

of

lipopolysaccharide (LPS), although levels of IL10 were decreased by alcohol182.
Conversely, pretreatment of cultured microglia with alcohol blunted LPS-induced
production of nitric oxide, a marker of M1 activation183.
Recent studies are beginning to shed light on the mechanism by which
alcohol activates glial cells. Deletion of Toll-like receptor 4 (TLR4) blunted
alcohol-induced increases in pro-inflammatory cytokines, iNOS, and both
microglia and astrocyte activation in an animal model184. Importantly, deletion of
TLR4 prevented alcohol induced caspase-3 expression, providing further support
to the theory that neuroinflammation causes neuronal loss after alcohol184.
Furthermore, TLR4 knockout mice were resistant to alcohol-induced impairments
in behavior185. Alcohol activation of microglia may also be dependent on other
toll-like receptors including TLR2186 and/or TLR3187. There is also evidence to
suggest that alcohol increases mir155 and that this may mediate part of these
actions, as deletion of mir155 blunted alcohol-induced production of TNFα and
MCP1188.
The work of Zou and Crews showed that alcohol likely causes a
neuroimmune response by first acting on neurons and working through a nuclear
protein that has cytokine-like activity, called high-mobility group box 1 (HMGB1).
Alcohol was shown to increase HMGB1 secretion from neurons and other cells,
which binds to TLR4 on microglia and activates them, leading to increased
cytokine production and furthering neuroinflammation189.
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Some work has also been done in adolescents, showing that alcohol
partially activates microglia, although in this exposure it did not lead to increases
in measured pro-inflammatory cytokines190. Conversely, a study in which animals
were exposed to alcohol intermittently from adolescence into adulthood found
that alcohol decreased neuronal and glial cell numbers and found increases in
inflammatory markers191. Finally, one study found that alcohol increased GFAP
staining in both adults and adolescents, but that pro-inflammatory cytokine
production was increased only in adults and these effects were brain-region
dependent192.
Interestingly, it has even been suggested that neuroinflammation may play
a role in the actual addiction process. One study showed that injections of LPS
cause increased voluntary alcohol consumption in rodents193. Similarly, deletion
of certain neuroimmune genes reduced voluntary alcohol consumption in a
gender-specific manner194.

1.14 Neuroimmune System Implications in FASD
Compared to research in adults and adolescents, the possible role of the
neuroimmune system in FASD has been much less studied, however evidence in
this emergent field has already strongly implicated the neuroimmune system in
this disorder.
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1.14.1 Studies in 1st and/or 2nd Trimester Models
Early, binge-like alcohol exposure increases the number of microglia in the
white matter of the brain195. Likewise, exposure to alcohol throughout the first
and second trimesters increased the number of astrocytes and microglia in the
cerebellum in a dose –dependent manner196. A similar study showed an increase
in microglial number and that these cells exhibited more immature morphology
compared to controls197. Conversely, several studies have shown a decrease in
astrocyte number after prenatal alcohol exposure198,199, consistent with cell
culture studies which show that treatment with alcohol restricts astrocyte
proliferation200-202. Cell culture studies have implicated astrocytes, from pups
prenatally exposed to alcohol, in several negative outcomes for neuronal
plasticity, including reduced dendritic outgrowth203. Multiple studies have shown
that prenatal alcohol exposure does not seem to prime glial cells and influence
pro-inflammatory cytokine production in response to secondary insults204,205.
Conversely, anti-inflammatory fractalkine was found to be elevated by prenatal
alcohol exposure206.

1.14.2 Studies in 3rd Trimester Models
Studies in 3rd trimester models are summarized in Table 1.1 and the
overall hypothesis within the field is shown in Figure 1.3. A number of different
animal models and exposure paradigms have confirmed that 3rd trimesterequivalent alcohol can induce microglial activation in multiple brain regions207-211.
Similarly, increased pro-inflammatory cytokine production has been reported in a
number of studies, in several brain regions208,210,212,213; anti-inflammatory
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cytokines have also been shown to be elevated212-214. Although most studies
have assessed time points within 1 day of the last alcohol exposure, one group
has reported cytokine production to be elevated weeks after exposure212,213.
However, lower BACs (110 mg/dL) do not seem to increase cytokine production,
despite inducing microglial and astrocytic responses207. Interestingly, in this lower
dose study there was significant variability in the outcomes of the fetuses, with
one of 6 fetuses being unaffected and the other 5 having differential signs of
neuroinflammation and neuronal injury207. To the best of my knowledge this study
is the only study to use a 3rd trimester model and include an investigation into
astrocytes, reporting that signs of astrocyte activation correlated with microglial
activation207.

Table 1.1: Summary of Studies Investigating the Neuroimmune Reponse Following a 3
Trimester-Equivalent Exposure to Alcohol

rd

The symbol (X) refers to a positive finding, wheras an empty box indicates that this outcome was
not investigated.
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A study by Li and colleagues compared neuroinflammation resulting from
different exposures paradigms, finding that moderate alcohol exposure (BAC =
200 mg/dL) did not produce cytokine secretion or signs of neuronal loss.
However, higher doses (BAC = 350 mg/dL) after only one day of alcohol
exposure on P4 resulted in robust cytokine secretion and neuronal loss, while
that same dose from P4-9 further increased these measures210. Another group
reported signs of microglial activation within 4 hours of alcohol exposure, with full
activation by 16 hours, and that microglia appeared to be engulfing neuronal
processes211.

rd

Figure 1.3: Model of Current Theory of the Neuroimmune System Following 3 TrimesterEquivalent Exposure.
Microglia (red) become activated following alcohol exposure and release pro-inflammatory
cytokines and chemokines (yellow dots), which may contribute to neuronal damage/death.
Neuronal damage may stimulate further microglial activation. This model has been suggested to
apply in multiple brain regions.
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Several studies have investigated the effect of blunting neuroinflammation
of neuronal loss209,210,212,213. In all studies, preventing microglial activation and/or
cytokine secretion correlated with reduced neuronal loss. One group also
reported partial rescuing of behavioral deficits212,213, suggesting that antiinflammatory agents may be a potential therapeutic option in the treatment of
FASDs.
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2. Overview of Studies
2.1 Study #1 (moderate, long-term exposure)
“Effect of repeated alcohol exposure during the third trimester-equivalent on
messenger RNA levels for interleukin-1b, chemokine (C-C motif) ligand 2, and
interleukin 10 in the developing rat brain after injection of lipopolysaccharide”.
2.1.1 Rationale: A number of studies investigating the effect of postnatal alcohol
exposure (PAE) have shown that high dose, binge-like exposures can activate
the neuroimmune system208-210,213. However, whether or not neuroimmune
system activation occurs following lower doses of alcohol remains controversial.
Instead there has been speculation that lower doses of alcohol during this period
could have more subtle “priming” effects on neuroimmune system function. This
type of effect has been reported after infections and other insults during the early
postnatal period that resulted in permanent alterations in the programming of
neuroimmune cells215,216. This priming causes the cells to over-react to
subsequent stimulation, resulting in dramatically increased cytokine production,
and causing deficits in memory and learning. This could be especially relevant in
cases of FASD, as FAE increases the susceptibility to infections and severity of
inflammation217-219.
2.1.2 Hypothesis: Exposure to moderate, long-term alcohol during the 3rd
trimester-equivalent will not induce a basal increase in neuroinflammation, but
will re-program cells to over-react to subsequent insults.
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2.1.3 General Approach: We used a vapor chamber inhalation paradigm to
model exposure to moderate levels of alcohol during the entire 3rd trimesterequivalent to human pregnancy. To simulate a neonatal infection, pups were
injected with LPS or saline one day following the alcohol exposure paradigm.
Two hours post-LPS, the cerebellum, dentate gyrus, and cortex were collected.
mRNA was analyzed for expression of pro- and anti-inflammatory cytokines in all
four groups (control + saline, control + LPS, PAE + saline, PAE + LPS), and the
response to LPS was compared between the control and PAE groups. We
included both males and females for this study. Based on our hypothesis, we
expected to find that cytokine expression would not differ between the PAE and
control groups that were injected with saline. Since LPS has been shown to
dramatically increase cytokine production, we anticipated that injection of LPS
would result in an elevated expression of cytokines in both control and PAE
animals. However, we expected that PAE would potentiate this response,
resulting in an even larger increase in cytokine production.
2.1.4 Conclusion: As expected, LPS injections dramatically increased expression
of pro-inflammatory cytokines. However, we found that, in contrast to our
hypothesis, PAE had surprisingly little effect on neuroimmune system function.
The only significant difference between the two groups was that PAE blunted the
LPS-induced increase of IL1β in the cortex of female pups. Taken together with
the literature, these findings indicate that moderate, long-term exposure to
alcohol is less disruptive to the neuroimmune system than high-dose, acute
exposures. These results are discussed in more detail in chapter 3.
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2.2 Study #2 (binge-like exposure)
“Exposure of Neonatal Rats to Alcohol has Differential Effects on Cytokine Levels
in the Cerebellum and Hippocampus: Potential Role of Microglia and Astrocytes”.
2.2.1 Rationale: In study #1, we found that moderate alcohol exposure in the
postnatal period had little effect on the neuroimmune system. However, bingelike exposure to high doses of alcohol in the postnatal period has been shown to
cause both neurodegeneration and robust neuroinflammation, characterized by
increased cytokine production and microglial activation

42,208-210,212

. While most

studies within this field have focused on pro-inflammatory cytokine production,
PAE has also been shown to increase TGFβ212,214, indicating that there may be
an anti-inflammatory component. Recently, the concept of M1 and M2 pathways
of microglial activation has been introduced132. M1 activation is classified as proinflammatory and neurotoxic when prolonged, while M2 polarization is generally
anti-inflammatory and can be strongly neuroprotective. Importantly, it has been
shown that the activation state of microglia can change during the course of
neuroinflammation. Specifically, in a model of multiple sclerosis, Miron and
colleagues demonstrated that the initial neuroimmune response consisted of M1
polarized microglia, yet analyses performed at later time points revealed that
microglia had switched to a predominantly M2 phenotype, likely to aid in neuronal
survival

and

CNS

recovery135.

Since

models

of

PAE

that

result

in

neuroinflammation typically also cause neuronal loss, it is possible that there is
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an M2 component to aid with neuronal recovery. The original purpose of this
study was to investigate the specific phenotype of neuroimmune system
activation during PAE, and to see if it evolved over time.
2.2.2 Hypothesis: Acute binge exposure to alcohol in the 3rd trimester-equivalent
initially induces a M1 neuroinflammatory response, which eventually resolves into
a M2 anti-inflammatory response that mitigates alcohol-induced damage in some
brain regions.
2.2.3 General Approach: We designed and thoroughly characterized a PAE
paradigm that would mimic a binge-like exposure and reliably induce both
neuroinflammation and neuronal loss. We performed an analysis of both the
cerebellum and the hippocampus, to determine if effects were global or brainregion specific, and included behavioral assessments for the functioning of both
brain regions. For measurements of neuroinflammation and neuronal loss, we
included multiple time points throughout the exposure paradigm to investigate the
evolution of the neuroimmune response. Neuroimmune activation was assessed
by RT-PCR for expression of mRNAs for pro- and anti-inflammatory cytokines, as
well as immunohistochemistry for the morphology of astrocytes and microglia.
Neuronal loss was assessed by immunohistochemistry and neuronal number
was counted. The study was organized into the following specific aims:
Aim 1: Develop and characterize a model of 3rd trimester binge alcohol exposure
through vapor inhalation that reliably induces neuroimmune activation.
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Aim 2: Determine the effect of a binge-like alcohol vapor exposure during the 3rd
trimester-equivalent on the neuroimmune system and the type of response at
both the level of cytokine expression and microglial activation.
2.2.4 Conclusion: We found that acute binge-like exposure to alcohol induced a
robust neuroimmune response within the cerebellum, as well as increased
neuronal loss. Conversely, in the hippocampus no neuronal loss was observed,
and there was little evidence of microglial activation. Interestingly, astrocyte
activation occurred in both brain regions. Furthermore, there did not seem to be a
distinct M1 or M2 type response, instead pro and anti-inflammatory cytokines
were up-regulated in both brain regions. However, pro-inflammatory cytokine
production spiked in periods of withdrawal, and returned to baseline during peak
BACs, while anti-inflammatory cytokine production was subtler, yet prolonged.
Results of this study are discussed in more detail in chapter 4.
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3.1 Abstract
Microglia undergo maturation during the third-trimester of human
development (equivalent to the first 1-2 weeks of postnatal life in rodents), during
which these cells may be particularly sensitive to insult. Alcohol exposure during
this period can activate the neuroimmune system, an effect that may contribute
to the pathophysiology of fetal alcohol spectrum disorders. Here, we investigated
whether repeated alcohol exposure during the third-trimester-equivalent in rats
has a priming effect on the neuroimmune response to injection of bacterial
lipopolysaccharide (LPS). Pups were exposed to alcohol in vapor chambers for
four hours daily from postnatal day (PD)2 to PD16 (peak blood alcohol
concentrations ~ 150 mg/dL). On PD17, rats were injected with either saline or
LPS (50 µg/kg) and the frontal cortex, cerebellar vermis, and dentate gyrus were
collected 2 hours later. Messenger RNA (mRNA) levels for the pro-inflammatory
agents interleukin 1β (IL-1β) and chemokine (C-C) motif ligand 2 (CCL2), as well
as levels of the anti-inflammatory cytokine interleukin 10 (IL-10), were measured
using

reverse

transcriptase-polymerase-chain

reaction.

LPS

consistently

increased IL-1β and CCL2 mRNA levels in the dentate gyrus, frontal cortex, and
cerebellum of both male and female rats. Furthermore, the LPS-induced increase
of IL-1β mRNA levels was significantly blunted in the frontal cortex of alcoholexposed female rats. Conversely, LPS only minimally affected IL-10 mRNA
expression and there were no significant differences between air and alcoholexposed rats. These findings suggest that exposure to comparatively moderate
alcohol levels during the third trimester equivalent has relatively subtle effects on
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the neuroimmune response after an immune challenge in the developing rat
brain.
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3.2 Introduction
Alcohol consumption during pregnancy is the most common cause of
preventable birth defects. The term fetal alcohol spectrum disorders (FASDs)
encompasses the molecular and functional consequences resulting from
developmental alcohol exposure, ranging from isolated behavioral deficits,
particularly in learning and memory, to a constellation of morphological and
behavioral alterations characteristic of fetal alcohol syndrome. It is estimated that
the prevalence of FASDs in the United States is approximately 2-5%3. Recent
studies have presented evidence for a role of the neuroimmune system in
FASDs220
Immune responses in the central nervous system (CNS) are the outcome
of interactions between many cell types such as glial cells (microglia, astrocytes,
oligodendrocytes), neurons in the surrounding tissue, and invading peripheral
components. Of these cells, microglia are the most well-characterized and widely
studied with respect to neuroimmune system function. Microglia are dynamic
cells that undergo a spectrum of changes in morphology, phenotype, and gene
expression upon activation. The response generated by microglia is highly
dependent on factors such as type of insult, duration, and individual features of
the host including gender and age. Typical microglial activation involves the
secretion of cytokines and chemokines which have been identified as powerful
modulators of the CNS influencing neuronal plasticity155,221, receptor activity and
expression222, neurogenesis216, and maintenance of homeostasis223,224.

The

neuroimmune system plays a particularly critical role during development and
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infections in the early postnatal period can impair cognitive functions in
adulthood215,225 and increase susceptibility to neurodevelopmental disorders226.
Additionally, microglia undergo maturation during the rodent third-trimester
equivalent of human pregnancy, which takes place postnatally, possibly leading
to an increased vulnerability to insult during this time163. It has been postulated
that neonatal infection programs an exaggerated response in the developing
neuroimmune system that could result in behavioral alterations such as memory
impairment227.
Alcohol intake has been shown to activate microglia, resulting in a
neurotoxic increase in pro-inflammatory cytokines175,187,190 a pattern of activation
known as the “classical” M1 response. Conversely, recent research has
emphasized the complexity of this system by demonstrating that microglia may,
under some conditions, instead assume a neuroprotective role (denoted as
“alternative activation” or M2 response)228 after alcohol exposure, characterized
by production of anti-inflammatory factors such as interleukin (IL)-10181.
Additionally, Kane and colleagues have shown an age-dependent neuroimmune
response to alcohol192, highlighting the importance of discrete developmental
stages in neuroimmune function. Additional studies have revealed that
gestational alcohol exposure is associated with increases in microglial and
astrocyte activation195-197. Furthermore, studies focusing on the third-trimester
equivalent have shown increases in pro-inflammatory cytokines and microglial
activation

in

several

brain

regions,

hippocampus209,212.
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including

the

cerebellum

and

Perturbation of the neuroimmune system by developmental alcohol
exposure may contribute to the pathophysiology of FASD in multiple ways. It
could directly disrupt CNS synaptic refinement by altering levels of cytokines
known to effect neuronal plasticity155,229 or by changing microglial phenotype,
thereby disrupting normal microglial-dependent processes such as synaptic
pruning170.

Conversely,

developmental

alcohol

exposure

could

act

by

programming a permanently altered neuroimmune system. In support of this
notion, FASD offspring have been shown to have impaired immune responses in
adulthood 218. Furthermore, the prevalence of neonatal infection in FASD patients
is increased dramatically, as even small amounts of alcohol during gestation are
associated with a 2.5 fold increase in risk for infection, whereas excessive
alcohol intake increases the risk by 3-4 times 219. A neuroimmune system altered
by alcohol exposure during development could react differently to a second insult
(such as neonatal infection) than that of a normal infant. The relationship
between the co-exposure to alcohol and neonatal infection could have critical
implications for the pathophysiology of FASD.
The objective of this study was to characterize neuroimmune function in
response to repeated third-trimester-equivalent alcohol exposure after a “second
insult” in the form of injection of a low dose of bacterial lipopolysaccharide (LPS).
We included both male and female pups, and focused on the dentate gyrus (DG)
subregion of the hippocampus as well as the cerebellum and frontal cortex.
These brain regions have been shown to be susceptible to damage by
developmental alcohol exposure32,230-233 that could be mediated, in part, by
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neuroimmune alterations209,212. To assess the function of the neuroimmune
system, we measured changes in mRNA levels for the pro-inflammatory markers,
interleukin-1β (IL-1β) and chemokine (C-C motif) ligand 2 (CCL2) whose
expression in the neonatal brain increases after LPS injections234. Additionally, to
determine if postnatal alcohol exposure (PAE) may induce an anti-inflammatory
effect, we measured mRNA levels for IL-10 which has been shown to increase
after LPS injections in the hippocampus of male rat pups234.
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3.3 Materials and Methods
3.3.1 Animal treatments and tissue collection
Animal procedures were approved by the Institutional Animal Care and
Use Committee of the University of New Mexico Health Sciences Center and
conformed to National Institutes of health guidelines. Time-pregnant Long-Evans
rats (gestational day 14-15) were obtained from Harlan Laboratories Inc.
(Indianapolis, IN) and allowed to acclimate for approximately one week before
giving birth. Two days after litter birth, dams and their respective offspring were
housed together in a vapor chamber apparatus. Starting at 10:00 am, litters were
exposed to 3.2 ± 0.4 mg/dL alcohol via vapor inhalation for 4 hours daily from
postnatal day (PD) 2 until PD 16 as described previously by

235

. Control litters

were housed similarly but received only air flow (no alcohol). Litters were culled
to 10 pups on PD 5. Blood alcohol concentrations (BACs) were determined using
an alcohol dehydrogenase-based assay, as previously described236. Rats were
given intraperitoneal injections of LPS (50 µg/kg body weight in ~90 µL) (Millipore
0111:B4, lot# 2089863) or endotoxin-free saline (Santa Cruz Biotechnology,
sc286637, lot#F0513) ~24 hours after the last alcohol exposure (on PD17). LPS
doses were chosen based on previous reports showing significant effects on
immune system gene expression234. Furthermore, this dose is on the lower end
of what is reported in the literature and has been shown to produce submaximal
activation of the neuroimmune system 237,238, therefore avoiding possibly masking
any effect of PAE on the response to LPS via a “ceiling” effect. Samples were
collected 2 hours after LPS injections, as described below. Animals received
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ketamine (250 mg/kg) by intraperitoneal injection and brains were removed by
decapitation. Brains were placed into ice cold phosphate buffered saline and
whole dentate gyri were extracted from both hemispheres as described
previously

239

. In addition, frontal cortex and cerebellar vermis samples were

collected. A minimum of 6 animals per experimental group were chosen based
on an a priori power calculation performed using the standard deviation and
effect size obtained in a previous study182. This experimental sample size is also
consistent with previous reports that have detected changes in LPS-induced
neuroinflammation after exposure to insult, including alcohol182,215,227.

3.3.2 Real-time PCR analysis
For RNA isolation, tissue was placed into Buffer RLT (Qiagen RNeasy
Mini Kit, Cat. No. 74106) containing 40 mM dithiothreitol. Samples were
homogenized by sonication and RNA was extracted immediately after tissue
removal using an RNeasy mini Kit (SABiosciences/Qiagen) according to the
manufacturer’s instructions. The RNA was frozen at -20 °C until use. cDNA was
synthesized

from

1

µg

of

RNA

using

the

RT2

First

Strand

Kit

(SABiosciences/Qiagen) and stored at -20 °C. Gene expression was measured
using real-time PCR. All primers were purchased from SABiosciences/Qiagen
including IL-1β (Cat No. PPR06480B) CCL2 (Cat. No. PPR06714B), IL-10 (Cat
No. PPR06479A) and hypoxanthine phosphoribosyltransferase 1 (Hprt1; Cat. No.
PPR42247F). PCR was carried out according to the RT2 qPCR Primer assay
instructions (SABiosciences/Qiagen) in combination with the RT2 SYBR Green
qPCR Master Mix. The threshold amplification number (CT) value for each gene
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of interest (GOI) was normalized to the housekeeping gene (HKG) Hprt1
following the formula ΔCT = CT (GOI) – CT (HKG). To validate the use of HPRT1
as a housekeeping gene, its expression was measured and found to be
unaffected by vapor chamber treatment (alcohol versus air control), injection
(LPS versus saline), or sex (data not shown). To avoid the potential of a floor
effect, a cut-off CT value of 35 was used.

3.3.3 Statistics
Data analysis was carried out on Prism 6.03 (GraphPad Software, San
Diego, CA). Whether the data followed a Gaussian distribution was determined
with Shapiro-Wilk or Kolmogorov-Smirnov normality test, and statistics were
determined by either parametric tests (one-sample t-test vs. a theoretical mean
of 1 and two-tailed student’s t-test or by non-parametric tests (Wilcoxon sign test
vs. a theoretical mean of 1 and Mann-Whitney test), as appropriate. The unit of
determination is defined as the average of results obtained with two male or two
female pups per litter.
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3.4 Results
To model human fetal alcohol exposure during the third-trimester of
pregnancy, rat pups were exposed daily to alcohol in vapor inhalation chambers
between PD2 and PD16, as previously described

235

. Chamber levels remained

relatively stable during exposure and pups were exposed to alcohol vapor levels
near 3 g/dL (data not shown). On PD2, prior to culling, approximately equal sized
litters were assigned to either the postnatal alcohol exposure (PAE) or air control
groups (Control group: 9.769 ± 2.048; PAE group: 11.08 ± 1.935; p = 0.1072, n =
13, by unpaired t-test). With the exception of cage changes on PD2, PD7 and
PD14, pups were unhandled and no mortality occurred. Peak BACs immediately
following exposure to alcohol were 155 ± 37.59 mg/dL and 164 ± 46.61 mg/dL on
PD 6 (n = 4 litters) and PD16 (n = 3 litters), respectively. These levels reflect a
BAC of approximately twice the legal limit of intoxication (80 mg/dL). Analysis of
pup weight on PD17 showed a significant decrease in the PAE group compared
to air control rats (Control group: 34.74 ± 3.616 g, n = 12 litters; PAE group:
32.01 ± 2.131 g, n = 11 litters; p = 0.0123, by Mann Whitney test).

3.4.1 Alcohol exposure does not significantly alter the neuroimmune
response to LPS in the DG
On PD 17, 24 hours after completion of alcohol exposure, two pups from
each litter (one male, one female) received an LPS injection and two pups (one
male, one female) received a saline injection. After 2 hours, mRNA was
harvested and the levels of pro-inflammatory cytokine IL-1β and chemokine
CCL2 (also known as monocyte chemoattractant protein-1) were examined.
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Additionally, anti-inflammatory cytokine IL-10 mRNA was assessed. With respect
to saline injected rats, as expected, LPS injections significantly increased IL-1β
mRNA levels in the DG of both control (p = 0.002, n = 10, by one sample t-test
vs. one) and PAE (p = 0.0039, n = 10, by Wilcoxon Signed Rank Test vs. one)
male rats (Fig 3.1A). Similarly, LPS injections significantly increased IL-1β mRNA
levels in the DG of control (p = 0.0003, n = 10, by one sample t-test vs. one) and
PAE (p = 0.0071, n = 9, by one sample t-test vs. one) female rats (Fig 3.1B).
However, there was not a significant difference between the air control and PAE
groups in the LPS-induced increase of IL-1β mRNA levels in either males (Fig
3.1A, p = 0.2443, by Mann-Whitney test) or females (Fig 3.1B, p =0.6828, by
unpaired t-test).
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Figure 3.1: 3 Trimester-Equivalent Alcohol Exposure did not alter mRNA Expression of
IL-1β, CCL2, or IL-10 in the Dentate Gyrus of Male or Female Pups after LPS Injection.
Levels of IL-1β (A), CCL2 (C), and IL-10 (E) were determined in male pups after LPS injection
compared to saline-injected littermates. Levels of IL-1β (B), CCL2 (D), and IL-10 (F) were
determined in females after LPS injection compared to saline-injected littermates. The fold
change in mRNA expression represents the ratio of levels in LPS-injected pups over salineinjected littermates. (N.S. = not significant, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 vs. a theoretical
mean of 1).

LPS injections significantly increased CCL2 mRNA levels in the DG of
both control (p = 0.0024, n = 10, by one sample t-test vs. one) and PAE (p =
0.0069, n = 10, by one sample t-test vs. one) male rats (Fig 3.1C). LPS injections
also significantly increased CCL2 mRNA levels in the DG of both control (p =
0.002, n = 10, by Wilcoxon Signed Rank Test vs. one) and PAE (p = 0.0025, n =
9, by one sample t-test vs. one) female rats (Fig 3.1D). However, there was not a
significant difference between the air control and PAE groups in the LPS-induced
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increase of CCL2 mRNA levels in the DG of either males (Fig 3.1C, p = 0.5339,
by unpaired t-test) or females (Fig 3.1D, p = 0.7065, by Mann-Whitney test).
LPS injections significantly increased IL-10 mRNA levels in the DG of
control (p = 0.0135, n = 8, by one sample t-test vs. one) but not PAE (p = 0.0805,
n = 8, by one sample t-test vs. one) male rats (Fig 3.1E). In female rats LPS
injections did not significantly affect IL-10 mRNA levels in controls (p = 0.0915, n
= 10, by one sample t-test vs one), but did significantly increase levels in the PAE
group (p = 0.0078, n = 8, by Wilcoxon Signed Rank Test vs. one) (Fig 3.1F).
However, the fold change in IL-10 expression after LPS injection was not
significantly different between control and PAE in male (Fig 3.1E, p = 0.6472, by
unpaired t-test) and female (Fig 3.1F, p = 0.4038, by Mann-Whitney test) rats.

3.4.2 Alcohol exposure blunts the LPS-induced increase of CCL2 mRNA
levels in the frontal cortex of female rats.
With respect to saline injected rats, LPS injections significantly increased
IL-1β mRNA levels in the frontal cortex of both control (p = 0.0466, n = 8, by one
sample t-test vs. one) and PAE (p = 0.0156, n = 7, by Wilcoxon Signed Rank
Test vs. one) male rats (Fig 3.2A). Similarly, LPS injections significantly
increased the IL-1β mRNA levels in the frontal cortex of both control (p = 0.0156,
n = 7, by Wilcoxon Signed Rank test vs. one) and PAE (p = 0.0106, n = 8, by one
sample t-test vs. one) female rats (Fig 3.2B). PAE did not significantly alter the
LPS-induced increase of IL-1β mRNA in the frontal cortex of male rats (Fig 3.2A,
p = 0.1203, by Mann-Whitney test). Conversely, PAE significantly blunted the
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LPS-induced increase of IL-1β mRNA in female rats (Fig 3.2B, p = 0.0006, by
Mann-Whitney test).
LPS injections significantly increased CCL2 mRNA levels in the frontal
cortex of control (p = 0.0330, n = 8, by one sample t-test vs. one) and PAE (p =
0.0304, n = 7, by one sample t-test vs. one) male rats (Fig 3.2C). Similarly, LPS
injections significantly increased CCL2 mRNA levels in both control (p = 0.0156,
n = 7, by Wilcoxon Signed Rank Test vs. one) and PAE (p = 0.0158, n = 8, by
one sample t-test vs. one) female rats (Fig 3.2D). However, PAE did not
significantly alter the LPS-induced increase of CCL2 mRNA levels in either males
(Fig 3.2C, p = 0.1952, by unpaired t-test) or females (Fig 3.2D, p = 0.2785, by
Mann-Whitney test).
LPS injections did not significantly increase IL-10 mRNA expression in the
frontal cortex of control (p = 0.3828, n = 8, by Wilcoxon Signed Rank Test vs.
one) or PAE (p = 0.2936, n = 7, by one sample t-test vs. one) male rats (Fig
3.2E). Similarly, LPS injections did not significantly increase IL-10 mRNA levels
in control (p = 0.1157, n = 7, by one sample t-test vs. one) or PAE (p = 0.4119, n
= 8, by one sample t-test vs. one) female rats (Fig 3.2F).

There were no

statistically significant differences in IL-10 mRNA levels after LPS in control or
PAE samples from either male (Fig 3.2E, p >0.9999, by Mann-Whitney test) or
female rats (Fig 3.2F, p = 0.0594, by unpaired t-test).
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Figure 3.2: 3 Trimester-Equivalent Alcohol Exposure blunted the LPS-induced increase in
IL-1β mRNA expression in the frontal cortex of female pups but not males.
The fold change in mRNA expression represents the ratio of levels in LPS-injected pups over
saline-injected littermates. Data is displayed as in Figure 3.1. The LPS-induced fold change in IL1β mRNA expression was significantly attenuated in female rats of the PAE group compared to
female rats in the air control group. (N.S. = not significant, * p ≤ 0.05 vs. a theoretical mean of 1,
*** p ≤ 0.001 vs. Air control).

3.4.3 Alcohol exposure did not significantly affect IL-1β or CCL2 mRNA
levels in the cerebellar vermis of male and female rats
With respect to saline injected rats, LPS injections significantly increased
IL-1β mRNA levels in the cerebellar vermis of both control (p = 0.0160, n = 8, by
one sample t-test vs. one) and PAE (p = 0.0200, n = 7, by one sample t-test vs.
one) male rats (Fig 3.3A). In female rats, LPS significantly increased IL-1β mRNA
levels in the cerebellar vermis of the control group (p = 0.0144, n = 7, by one
58

sample t-test vs. one) but not the PAE (p = 0.1251, n = 6, by one sample t-test
vs. one) group (Fig 3.3B). PAE did not significantly alter the LPS-induced
increase of IL-1β mRNA levels in either males (Fig 3.3A, p = 0.0993, by unpaired
t-test) or females (Fig 3.3B, p = 0.7949, by unpaired t-test).
LPS injections significantly increased CCL2 mRNA levels in the cerebellar
vermis of both control (p = 0.0390, n = 8, by one sample t-test vs. one) and PAE
(p = 0.0169, n = 7, by one sample t-test vs. one) male rats (Fig 3.3C). Similarly,
LPS injections significantly increased CCL2 mRNA levels in the cerebellar vermis
of both control (p = 0.0202, n = 7, by one sample t-test vs. one) and PAE (p =
0.0305, n = 6, by one sample t-test vs. one) female rats (Fig 3.3D). PAE did not
significantly alter the LPS-induced increase of CCL2 mRNA expression in either
males (Fig 3.3C, p = 0.2643, by unpaired t-test) or females (Fig 3.3D, p = 0.8171,
by unpaired t-test).
LPS injections did not significantly increase IL-10 mRNA expression in
control (p = 0.2791, n = 8, one sample t-test vs. one) or PAE (p = 0.0863, n = 6,
by one sample t-test vs. one) male rats (Fig 3.3E). Similarly, LPS injection did not
increase IL-10 mRNA expression in controls (p = 0.2188, n = 7, by Wilcoxon
Signed Rank Test vs. one) or in PAE (p = 0.2062, n = 6, by one sample t-test vs.
one) female rats (Fig 3.3F). There were no statistically significant differences in
IL-10 mRNA levels after LPS in control or PAE samples from either male (Fig
3.3E, p = 0.7979, by unpaired t-test) or female rats (Fig 3.3F, p > 0.9999, by
Mann-Whitney test).
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Figure 3.3: 3 Trimester-Equivalent Alcohol Exposure did not alter mRNA Expression of
IL-1β, CCL2, or IL-10 after LPS Injection in the Cerebellar Vermis of Male or Female pups.
The fold change in mRNA expression represents the ratio of levels in LPS-injected pups over
saline-injected littermates. Data is displayed as in Figure 3.1. (N.S. = not significant, * p ≤ 0.05 vs.
a theoretical mean of 1)
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3.5 Discussion
This study examined the effect of a repeated third-trimester equivalent
alcohol exposure on the developing neuroimmune system, concentrating on the
interaction of developmental alcohol exposure with a LPS challenge in the rat
neonatal period. Many previous studies have demonstrated that neuroimmune
activation during the neonatal period can reprogram this system, resulting in
long-term deficits that are subtle and essentially undetectable until unmasked by
a second insult. The reprogrammed neuroimmune system then over-reacts to
later insults with increased pro-inflammatory cytokine production eliciting
behavioral deficits215,216,225,240. Based on these studies, we hypothesized that
ethanol could produce a similar effect; i.e., that exposure to moderate ethanol
levels during late stages of pregnancy could program the neuroimmune system
to have an exaggerated pro-inflammatory response to an infection, leading to
secondary CNS damage. Contrary to our hypothesis, we found that exposure to
relatively moderate alcohol levels during the third trimester-equivalent had little
effect on neuroimmune function in response to LPS injections. Moreover, PAE
had an effect opposite what we expected in the frontal cortex of female rats,
where it actually blunted the LPS-induced production of IL-1β mRNA.
Using a previously characterized vapor chamber exposure paradigm235,
we exposed rats to alcohol through vapor inhalation for 2 weeks, from PD2 to 16,
which encompasses several of the developmental events that occur in the
human brain during the third trimester of human pregnancy241. Unlike humans,
rodents undergo the brain growth spurt associated with the human third trimester
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of gestation during the early postnatal period. This period includes key brain
developmental processes, such as synapse formation and elimination11. While
our paradigm only models alcohol consumption during the third trimester
equivalent without any exposure in the first or second trimesters, this has been
identified as the third most common drinking pattern during pregnancy in the
US5. Our laboratory has previously found that this alcohol model, using a slightly
higher BAC, induces alterations in GABAergic subunit expression in the
cerebellum242,

GABAergic

transmission243

and

LTP

induction

in

the

hippocampus35. However, using lower doses, as in this study, ethanol did not
significantly affect either LTP in the hippocampus35 or complex spikes and longterm depression in cerebellar Purkinje neurons235. Additionally, apoptotic
neuronal cell death has not been shown to occur at the BACs used in this
study42. Therefore, we did not expect that the more moderate level of alcohol
exposure in this model would cause large changes, but instead sought to
investigate whether it might cause more subtle changes in the neuroimmune
system that could be unmasked with a second insult (LPS).
Using this paradigm, we attained peak BACs that were approximately
twice the legal limit of intoxication (80 mg/dL) and could be achieved by a
pregnant woman consuming around 5-6 drinks244. Therefore, these levels of
alcohol exposure are considered high from the human perspective. However,
previous studies have shown that rodents are more resistant to alcohol than
humans and higher BACs are needed to elicit similar effects in the former16.
Using a similar paradigm, our laboratory has previously shown that after this type
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of exposure, BACs gradually return to zero over the course of approximately 8
hours

242

. The current study uses pointedly lower BACs, which likely return to

baseline in less time. While we did not observe an increase in mortality, there
was a significant decrease in body weight in PAE rat pups on PD17. Therefore,
this paradigm models some of the characteristics of fetal alcohol syndrome which
is, in part, characterized by decreased body weight.

3.5.1 Alcohol exposure did not affect the LPS-induced increase in IL-1β,
CCL2, and IL-10 mRNA in the DG.
We investigated the effect of PAE followed by immune challenge with a
low dose of LPS in order to mimic an infant prenatally exposed to ethanol
contracting an infection soon after birth. We gauged the neuroimmune proinflammatory response to LPS by measuring the expression of IL-1β and CCL2
mRNA, both of which have shown to be significantly elevated after LPS injection,
and are regularly used as markers of neuroinflammation234. Additionally, we
measured the anti-inflammatory cytokine IL-10, which has been shown to be
elevated in the hippocampus of male pups after LPS234.We therefore expected
that IL-10 mRNA would be elevated in other brain regions as well. Two hours
after LPS injection, we observed a significant increase in both pro-inflammatory
genes in the DG, with a larger increase in CCL2 expression (~20 fold) than in IL1β (5-10 fold), consistent with previous findings234. Conversely, we did not detect
robust changes in IL-10 mRNA expression in rats injected with LPS.
Previous studies investigating the role of the neuroimmune response after
PAE have focused primarily on male rats. Given the sexually dimorphic effects of
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PAE245-247, as well as the striking gender differences in microglia colonization
during development

164

, we included both males and females in this study. In the

DG, we detected no difference in the LPS-induced pro-inflammatory response
between males and females. However, there was a highly variable response to
LPS across rats within the same treatment groups, with some animals having
very little increase in pro-inflammatory gene production and others having a
much more pronounced effect. This may be explained by non-overt differences in
maternal care or environmental factors, such as prenatal exposure to stress, as
these have been shown to affect the neuroimmune system248,249. Future studies
should assess this possibility.
A peripheral injection of a low dose of LPS is expected to induce
neuroinflammation indirectly given that it does not penetrate the CNS at
significant levels250. LPS is known to increase both cytokine levels in the
periphery and blood brain barrier permeability, potentially allowing cytokines from
the periphery to enter the CNS251,252. Therefore, changes in CNS cytokine levels
could be due in part to invasion of peripheral immune components, such as direct
permeation by IL-1β or chemotactic macrophages. Additionally, peripheral
immune system infiltration would likely activate neuroimmune cells and induce a
local response. Importantly, with the exception of the female frontal cortex, our
PAE paradigm did not alter the inflammatory response created by peripheral LPS
injections, meaning that the pathway of activation is generally still intact.
Alcohol exposure during the third-trimester equivalent has been shown to
cause neuroimmune activation in the hippocampus, including an increase in
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several pro-inflammatory markers such as IL-1β212; however, BACs were more
than twice as high as those used in the current study. Additionally, the route (i.e.
intragastic gavage vs. vapor inhalation) and duration (acute vs. chronic) of
alcohol administration could contribute to the observed discrepancies between
studies.
With regard to the possibility of an anti-inflammatory response, we found
that IL-10 expression was increased after LPS in the DG of male controls, but in
the females this increase was only significant in the PAE group. Futhermore,
there were no significant differences in IL-10 expression after LPS between the
PAE and air control rats in either males or females. Thus it is likely that no
difference in anti-inflammatory IL-10 expression exists between the two groups in
this exposure paradigm. Our findings in the males are consistent with a previous
study showing a similar fold increase in IL-10 two hours after LPS injection in the
hippocampus of male rat pups234. It is unclear why IL-10 production after LPS
injection did not also increase in the female rats. While the ability of IL-10 to
block the production and function of many pro-inflammatory cytokines is wellestablished253,254, it has also been suggested that pro-inflammatory cytokines
may increase the expression of IL-10255-257 acting as an inflammatory brake
system. Additionally, IL-10 production has been shown to occur as a result of the
activation of specific pathways, such as the p38 MAPK pathway, that are also
associated with the production of pro-inflammatory cytokines,

including IL-

1β257,258. Therefore, we expected the increased pro-inflammatory cytokine
expression to be accompanied by an increase in IL-10. Surprisingly this was not
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typically the case, suggesting that our paradigm does not engage a strong antiinflammatory response, at least at the time we performed our assays. This could
be due, in part to the timing of our assay. We collected mRNA samples 2 hours
after LPS expression, at which time pro-inflammatory cytokine expression is
reliably increased. Conversely, IL-10 has been suggested to occur on a
comparatively delayed timescale254,257 and consequently it is possible that we
missed the peak elevation in IL-10.

3.5.2 Alcohol exposure blunts the LPS-induced increase of IL-1β mRNA in
the cortex of female rats.
In the cortex of control animals, LPS injections produced a significant
increase in production of IL-1β and CCL2 mRNA in both males and females. This
response was very similar to that seen in the DG, with a slightly larger increase in
CCL2 mRNA than for IL-1β. However, in PAE female rats the LPS-induced
production of IL-1β mRNA was significantly blunted. These findings are
consistent with previous studies showing that alcohol exposure has regionspecific, selective effects on particular cytokines192. While the IL-1β and CCL2
pathways are highly interconnected, the two have different functions. We
consistently observed a more pronounced response in CCL2 than IL-1β,
indicating that perhaps the subtle impact of PAE on this system only significantly
affected the less robust IL-1β response to LPS.
In addition to blunting the response in a cytokine-selective manner, PAE
also induced a gender-specific effect. As mentioned previously, the effects of
PAE are sexually dimorphic and the development of the neuroimmune system is
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different between males and females. Specifically, microglia in juvenile female
rats exhibit a more activated morphology than juvenile male rats, are slower to
colonize the postnatal brain, and males and females exhibit different gene
expression profiles of inflammatory cytokines and chemokines164. A combination
of these factors could contribute to sex-dependent differences in the effect of
PAE observed in the current study. Finally, the effects being region-specific to
the cortex may result in PAE offspring having problems with executive, higher
functioning, as has been observed in patients with FASD259. These findings are
also consistent with the literature on the effect of ethanol in the adult brain where
region specific changes in neuroinflammation have been identified192. Finally,
while no significant increase in IL-10 was observed after LPS injection in the
frontal cortex of either male or female rats pups, in the female pups there was a
strong trend toward decreased IL-10 expression, suggesting that the decrease in
IL-1β is not due to an increased anti-inflammatory response, but may instead be
due to a diminished overall neuroimmune response, which may be related to
toxic effects of PAE on developing microglia209.
Based on the literature and the idea of neuroimmune system “priming”, we
hypothesized that PAE would increase the response to a second insult, eliciting
an over-reaction. However, we observed instead that PAE had the opposite
effect, blunting the neuroimmune response in the female frontal cortex. Therefore
the PAE-induced weakening of the neuroimmune response, could leave the CNS
more susceptible to damage by infection, as activation of this system plays an
important role in the destruction of pathogenic agents, removal of damaged cells,
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and stimulation of repair processes84. Further studies are needed to address
these possibilities.

3.5.3 Alcohol exposure does not affect the LPS-induced increase in IL-1β
and CCL2 mRNA in the cerebellar vermis.
In the cerebellar vermis, LPS injections elicited similar effects in control
animals as seen in both the DG and frontal cortex. As expected, LPS induced a
significant increase in mRNA expression of CCL2 and IL-1β in both males and
females. This effect was not significantly altered by PAE for either sex.
Additionally, IL-10 was not found to be significantly altered by LPS injections,
suggesting that this anti-inflammatory pathway is not engaged in the cerebellar
vermis in response to LPS injection, further highlighting the brain regional
differences in neuroinflammation at this age. Previous studies utilizing a third
trimester binge-like alcohol exposure paradigm have identified both increases in
basal levels of pro-inflammatory markers212 and microglial activation209 in the
cerebellum. However, these studies employed higher doses of alcohol yielding
BACs of more than twice the peak BACs found here, and used different methods
of administration than the one used in our study (gavage versus inhalation).
Differences in paradigm likely play a role in the discrepancies observed in the
current report.

3.5.4 Overall Conclusion.
To our knowledge, this is the first study of the impact of PAE on
neuroimmune activation induced by LPS injection during the neonatal period. We
found that, in most cases, PAE had very little effect on neuroimmune function as
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in response to a second insult. Importantly, PAE selectively blunted the LPSinduced production of IL-1β mRNA in the cortex of female rats. Taken together
with the collective findings regarding third trimester alcohol exposure and the
neuroimmune system220, our findings suggest that chronic exposure to lower
levels of alcohol is less disruptive to the neuroimmune system than binge-like
exposure to high doses of alcohol.
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4.1 Abstract
Background: Fetal alcohol exposure is a leading cause of preventable birth
defects, yet drinking during pregnancy remains prevalent worldwide. Studies
suggest that activation of the neuroimmune system plays a role in the effects of
alcohol exposure during the rodent equivalent to the third trimester of human
pregnancy (i.e., first week of neonatal life), particularly by contributing to neuronal
loss. Here, we performed a comprehensive study investigating differences in the
neuroimmune response in the cerebellum and hippocampus, which are important
targets of third trimester-equivalent alcohol exposure.
Methods: To model heavy, binge-like alcohol exposure during this period, we
exposed rats to alcohol vapor inhalation during postnatal days (P)3-5 (blood
alcohol concentration = 0.5 g/dL). The cerebellar vermis and hippocampus of rat
pups were analyzed for signs of glial cell activation and neuronal loss by
immunohistochemistry at different developmental stages. Cytokine production
was measured by reverse transcriptase polymerase chain reaction during peak
blood alcohol concentration and withdrawal periods. Additionally, adolescent
offspring were assessed for alterations in gait and spatial memory.
Results: We found that this paradigm causes Purkinje cell degeneration in the
cerebellar vermis at P6 and P45; however, no signs of neuronal loss were found
in the hippocampus. Significant increases in pro-inflammatory cytokines were
observed in both brain regions during alcohol withdrawal periods. Although
astrocyte activation occurred in both the hippocampus and cerebellar vermis,
microglial activation was observed only in the latter.
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Conclusions: These findings suggest that neuroinflammation following third
trimester alcohol exposure is time- and brain region- dependent, and that
astrocytes may play an important role in this response.

73

4.2 Background
Drinking during pregnancy can result in fetal alcohol spectrum disorders
(FASDs), an umbrella term used to describe a wide array of teratogenic effects
that occurs in an estimated 2-5% of live births in the United States3. FASD range
from the most severe form, fetal alcohol syndrome, to less obvious
neurocognitive deficits and behavioral abnormalities. Although the mechanisms
underlying FASD are not fully understood, one of the most detrimental effects of
alcohol exposure in the developing brain is neuronal loss42,72,260. Recently,
activation of the neuroimmune system has been observed in parallel with
neurodegeneration and this effect has been suggested to play a central role in
the pathophysiology of FASD.
The neuroimmune system is comprised primarily of microglia and
astrocytes, although microglia are much better characterized with respect to this
system. Along with their critical functions in defending the CNS from damage,
astrocytes and microglia have important roles during development, particularly in
synaptic refinement170,261. Both cell types undergo maturation concurrent with the
brain growth spurt160,169, which occurs during the third trimester of human
pregnancy and is equivalent to the early postnatal period in rodents, suggesting
that these cells may be particularly vulnerable to insult during this time. While
considerable research has been conducted into alcohol’s neuroinflammatory
effects

in

adolescents

and

adults175,179,181-183,188,190,192,262,263,

the

unique

neuroimmune response to alcohol during development has only begun to be
investigated.
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Research focused on prenatal alcohol exposure (i.e., first- and secondtrimester-equivalent exposure) have indicated an increased number of
microglia/macrophage throughout brain white matter195 and in the cerebellum196,
and a reduced number of Bergmann glial cells199. Models utilizing cell culture or
in-vivo prenatal exposure have shown that astrocytes can contribute to repair
processes engaged in response to alcohol exposure, including promoting
neuronal survival, dendritic outgrowth, and plasticity203.
Additionally, studies in models of third trimester-equivalent alcohol
exposure have demonstrated elevations in pro-inflammatory cytokines in multiple
brain regions208,210, which were long-lasting in some cases212, and widespread
signs of neuronal loss42. Moreover, blunting neuroinflammation correlated with
decreased neuronal loss209,210 and improved performance in hippocampaldependent tasks212. Based on these results, it was concluded that neuroimmune
activation contributes to neuronal loss across several brain regions. Additionally,
while postnatal alcohol exposure (PAE) has been shown to activate
microglia209,211, a potential role for astrocytes in the neuroimmune response to
PAE received little attention, despite the fact that astrocytes commonly secrete
cytokines in response to CNS insults264 and regulate microglial activation139.
Furthermore, a more comprehensive analysis of the neuroimmune response to
multiple alcohol exposures during development, including the individual effect of
withdrawal periods, has yet to be undertaken.
In this study, we further characterized the effect of alcohol exposure
during the third trimester-equivalent on the neuroimmune system. To investigate
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the relationship between neuronal loss and neuroimmune activation, we utilized a
paradigm designed to induce neurodegeneration and compared the respective
neuroimmune responses in the cerebellum and hippocampus. We included end
points collected during periods of both peak blood alcohol levels and withdrawal.
These end points incorporate an investigation into both astrocyte and microglial
activation with an in-depth analysis of the specific layers in which activation of
these cells occurs, with respect to neuronal loss. In addition, we measured
mRNA levels for both pro- and anti-inflammatory cytokines.
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4.3 Materials and Methods
4.3.1 Animal treatments
Animal procedures were approved by the Institutional Animal Care and
Use Committee of the University of New Mexico Health Sciences Center. Timepregnant Sprague-Dawley rats were obtained from Harlan Laboratories Inc.
(Indianapolis, IN) and allowed to acclimate for one week before giving birth. Only
male offspring were used for experiments, as developmental alcohol exposure
has been shown to have sexually dimorphic effects245-247 and microglial
colonization of the brain is different in males and females164. Previous studies
have demonstrated that binge-like exposure to high levels of alcohol is effective
at inducing neuronal cell loss in the rodent brain42. Additionally, binge-like, heavy
alcohol-exposure paradigms in the early postnatal period have been shown to be
more effective in generating a robust neuroimmune response209,210,212 when
compared to more moderate, but long-term exposures265. Importantly, heavy
alcohol exposure during late pregnancy has been documented in humans

4,244

.

We chose to expose pups to higher levels of alcohol than those typically
achieved in humans because the developing rodent brain is comparatively more
resistant to alcohol than the human brain16,17. We used a vapor inhalation
paradigm because it is less invasive than other methods, requires minimum pup
handling, and allows pups to remain with their mothers throughout exposure.
Three days after litter birth, dams and their respective offspring were
housed together in the vapor chamber apparatus. Litters were randomly
assigned to either alcohol treatment or control. Starting at 10:00 am, litters were
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exposed to alcohol via vapor inhalation for 4 hours daily during their light cycle,
from postnatal day (P)3 through P5, a period of exposure that has previously
been shown to activate the neuroimmune system209. Alcohol vapor levels were
8.03 g/dL ± 0.21 at 4 hours (n = 9 rounds of exposure). Control litters were
housed in identical chambers that had only air flowing through them. Pups were
handled daily only for weighing purposes. Blood alcohol concentrations (BACs)
were determined using an alcohol dehydrogenase-based assay, as previously
described236. On P4, BACs were measured at 0, 2, 4, 8, 12 and 21 hours after
exposure began, with 0 hours being the time immediately preceding exposure.
Maternal BACs were also measured in a separate group of dams subjected to
the 4 hour exposure paradigm after pups had been weaned.
Nursing ability was assessed by counting the number of pups in each litter
who had a visible presence of milk in their stomachs on the mornings after each
exposure day. Finally, maternal care was assessed as previously described266.
Briefly, on P4, starting at exposure hour 0, litters were filmed for 15 minutes out
of every hour during the 4 hour exposure, plus 4 additional hours following
exposure (8 total hours). Maternal behavior was scored by a blinded observer
every 3 minutes during each 15 minute clip for the following actions: no contact
with the pups, arched-back nursing, blanket nursing, passive nursing, licking
pups, and licking pups during arched-back nursing.
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4.3.2 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Samples were collected on P3 and P5 within 30 minutes following the 4
hour alcohol exposure, and during periods of alcohol withdrawal on P4 and P6.
Additionally, to address the duration of effects, samples were collected at P1113. Eight pups (from a total of 8 litters) were used per treatment group. Animals
were anesthetized with ketamine (250 mg/kg). Whole hippocampi and cerebellar
vermises were collected. Tissue was homogenized by sonication in ice cold
RNeasy Lysis Buffer and RNA was extracted using an RNeasy Mini Kit according
to the manufacturer’s instructions (SABiosciences/Qiagen, Valencia, CA). The
RNA was stored at -20 °C until use. cDNA was synthesized from 1 µg of RNA
using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, cat#
4368813, Foster City, CA) according to the manufacturer’s instructions. The
following

primers

from

Qiagen

were

used:

interleukin-1β (IL-1β,

cat#

PPR06480B), tumor necrosis factor α (TNFα, cat# PPR06411F), interleukin-10
(IL10, cat# PPR06479A), transforming growth factor β (TGFβ, cat# PPR06430B)
and hypoxanthine phosphoribosyltransferase 1(HPRT1, cat# PPR42247F). Only
samples with threshold cycle values (CT) over 35 were used for analysis. All
values were normalized to HPRT1 via the ΔΔCT method. HPRT1 was not
affected by PAE at any age in either the cerebellar vermis (interaction F(4,70) =
0.22, p = 0.929; alcohol F(1,70) = 0.20; p = 0.657; age F(4,70) = 2.50, p = 0.050, n
= 8 pups from 8 litters) or the hippocampus (interaction F(4,69) = 0.36, p = 0.836;
alcohol F(1,69) = 0.003, p = 0.956; age F(4,69) = 13.76, p < 0.0001, n = 7-8 pups
from 7-8 litters). Then, for each cytokine the average value of the P3 air control
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was computed and each individual data set was divided by this average,
including the P3 air control that was used to compute the average.

4.3.3 Immunohistochemistry
On P4, P6, and P45, 4 pups (from a total of 4 litters) per treatment group
were anesthetized by injection of ketamine (250 mg/kg). Animals were
transcardially perfused first with phosphate buffered saline (PBS), pH 7.4,
containing procaine hydrochloride (1 g/L) and heparin (1 USP unit/L) for 4
minutes, followed by ice cold 4% paraformaldehyde in PBS. Brains were
removed by decapitation and placed in 4% paraformaldehyde for 48 hours at
4oC, then 30% sucrose for 24-48 hours at 4oC. Brains were embedded in Optimal
Cutting Temperature compound (Fisher Healthcare, Houston, TX) and frozen
before sectioning on a cryostat (Microm, model# HM 505E, Walldorf, Germany)
at 16 µm. Sections for staining were incubated with PBS containing 1% bovine
serum albumin, 0.2% Triton X-100, and 5% of either donkey or goat serum to
match the host species of the secondary antibodies described below. Primary
antibodies were applied overnight at 4 °C. Astrocytes were stained with rabbit
anti-glial fibrillary acidic protein (GFAP, 1:500, Dako, ref# Z0334, Carpinteria,
CA), microglia with rabbit anti-IBA-1 (1:500, Wako, ref#Z0334, Richmond, VA),
Purkinje cells with mouse anti-Calbindin (1:500, Santa Cruz, cat# sc-70478,
Dallas, TX), hippocampal neurons with mouse anti-NeuN (1:500, Millipore, cat#
MAB377A5, Bedford, MA), neurofilament with mouse anti-neurofilament (1:500,
Abcam, cat# ab24574, Cambridge, MA) and cell nuclei with 4’,6-diamidino-2phenylindole (DAPI, 1:1000, cat# D3571, Life Technologies, Carlsbad, CA).
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Secondary antibodies were either donkey anti-rabbit or goat anti-mouse
conjugated to Alexa 555 (1:1000, Invitrogen, Waltham, MA) and were applied at
room temperature (20-22°C) for 2 hours.
All immunohistochemical analyses were performed by a blinded
researcher using ImageJ (NIH, Bethesda, MD). At least two sections per animal,
at least 5 sections apart, were averaged for each antibody. Sections were
imaged on a Nikon TE2000 microscope (Nikon, Melville, NY) with a nuance
spectral camera (Quorum, model# N-MSI-FX, Guelph, Ontario), which allows for
elimination of background and low-intensity fluorescence as previously described
267

. Images were taken at 20X and 60X for all but GFAP intensity, which was

imaged at 10X and 60X. Lobules of the cerebellar vermis have been shown to
have different sensitivities to PAE
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likely based on their rates of maturation.

Therefore, lobules were grouped into three regions for quantification; lobules I-III,
IV-VII, and IX-X. The hippocampus was divided by regions CA1, CA3, and the
dentate gyrus (DG).
For measurements of intensity, the region of interest was traced and
fluorescent intensity was quantified within. GFAP intensity was used to assess
astrocytes268 and staining for neurofilament was used to track Purkinje cell
maturation during the postnatal period269.
Microglia were stained with ionized calcium-binding adapter molecule 1
(IBA-1) and classified into one of four morphological stages, similar to as
previously described270,271. In brief, cell types were categorized as either
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resting/ramified (characterized by small cell body and long dendritic processes),
transitional 1 (slightly swollen cell body with thicker, shorter processes),
transitional 2 (large cell body with slight protrusion of processes) or amoeboid
(large, round cell body with no processes and more intensely stained with IBA-1).
To quantify neuronal numbers, the thickness of the cell layer and/or the
cell density was assessed. In the case of cell layer thickness, measurements
were made randomly in three separate locations and averaged per image. The
Purkinje cell layer (PCL) was traced in each image and the total area was
quantified. Purkinje cells within the layer were then counted and displayed as
cells per area, similar to as previously described272. In the hippocampus,
because of the large number of cells, density of the granule cell layer (GCL) in
the DG and the stratum pyramidale (SP) of the CA1 and CA3 were measured by
placing three 30 µm2 boxes at random in each region. The neurons within each
box were counted and averaged.

4.3.4 Gait Analysis
Alterations in gait are associated with cerebellar impairment and
particularly with Purkinje cell dysfunction273-275. Gait was assessed using the
Catwalk XT system (Noldus, Wageningen, Netherlands) located at Animal
Behavioral Core of the Biomedical Research and Integrative Neuroimaging
Center (BRaIN), UNM-HSC; 2-3 animals per litter were used from a total of 4
litters per treatment group. Rats aged P45-50 were placed on an enclosed glass
walkway illuminated from above by a red fluorescent light and along the walkway
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by green LED lights. Disruption of the green light allowed for tracking of paw
prints, while disruption of red light allowed for visualization of silhouettes. Rats
were allowed to walk freely across the runway to a dark box, containing bedding
from their home cage, located at the opposite end. A digital high-speed camera
recorded each trial until three compliant trials were captured in which the animal
did not stop or turn around and crossed the walkway within 0.5 - 10s with a
maximum body speed variation of less than 60%. PAE significantly increased the
total number of trials required to achieve 3 compliant trials, and these were 3.44
± 0.41 and 6.44 ± 1.28 trials for the control and alcohol groups, respectively (t(16)
= 2.23, p = 0.041, by unpaired t-test). After each trial, the walkway was wiped
down with 70% ethanol and deionized water. Catwalk XT 8.1 software (Noldus)
was used to analyze the data. A detailed description of the measured parameters
can be found in Table 4.2 (Additional File 3). For each animal, print area,
average print intensity, base of support, support %, print position, phase
dispersions, swing speed, cadence, and average speed were calculated, similar
to as previously described276. Parameters were analyzed for the right forepaw
(RF), right hind paw (RH), left forepaw (LF) and left hind paw (LH).

4.3.5 Contextual Fear Conditioning
Multiple pre-exposure contextual fear conditioning was used to test
hippocampal-dependent behavioral differences. Pre-exposing animals to the
context one day prior to shock conditioning, which has been shown to increase
freezing, is impaired in a model of neonatal alcohol exposure277. Animals aged
P36-48 were individually housed 1 day prior to testing. One animal per litter from
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5-7 litters per treatment group was used. Between animals, the chamber was
cleaned with ~5% ammonium chloride and left to dry for 2 minutes before the
next animal was placed into the chamber. Testing took place over 3 days. On
day 1, the animals were allowed to explore the chamber for 5 minutes. Then, the
animals were removed from the chamber for 1 minute and then returned to the
chamber for the next minute. This was repeated a total of 5 times before
returning the animal to the home cage. On the second day, animals were placed
into the chamber and received a 2s foot shock (1.5 mA) ~45-60 seconds later,
after which they were placed back into their home cage. On the final day of
testing, the animal was placed in the chamber for 5 minutes and total freezing
time, defined as the body becoming immobile without any licking or grooming
activity, was video-recorded and then scored by a blinded observer.

4.3.6 Statistical Analysis
All statistics were analyzed with GraphPad Prism Version 6.05
(GraphPad, San Diego, CA). Data were analyzed by student’s unpaired t-test or
two-way ANOVA followed by Bonferroni post hoc test. Significance was
determined as p < 0.05. Data are shown as mean ± SEM.
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4.4 Results
4.4.1 Characterization of the Exposure Paradigm
PAE significantly decreased pup body weight on P17 (Fig. 4.1a, two-way
ANOVA, interaction F(5,98) = 4.00, p = 0.002; age F(5,

98)

= 153.2, p < 0.0001;

alcohol F(1,98) = 12.01, p = 0.0008); Bonferroni post hoc test: p = 0.0004 on P17).
Nursing, as assessed by the proportion of pups with milk in their stomachs, was
not significantly affected by PAE (Fig. 4.1b, two-way ANOVA, interaction F(3,36) =
2.44, p = 0.080; age F(3,36) = 2.15, p = 0.111; alcohol F(1,36) = 0.73, p = 0.400).
Litter sizes were comparable between PAE and air control groups (Fig. 4.1c, t(32)
= 1.19, p = 0.242, unpaired t-test). In pups, BACs reached a peak of 121.1 ±
11.75 mM (0.56 ± 0.05 g/dL) at the end of exposure and returned to baseline by
the following morning (Fig. 4.1d). Conversely, peak maternal BACs were much
lower at 32.22 ± 8.49 mM (Fig. 4.1d). Measurements of maternal care were
unaffected by alcohol exposure (Table 4.1).
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Table 4.1. Assessment of Maternal Care

Characterization

Air (% of total
observation time

t
PAE (% of total
observation time)

p
value

No Contact with Pups

23.98 ± 4.05

12.50 ± 8.41

1.23

0.242

Licking Pups and ArchedBack Nursing

7.10 ± 2.16

3.95 ± 2.54

0.94

0.365

Arched-Back Nursing

29.86 ± 7.00

26.02 ± 9.51

0.33

0.751

Blanket Nursing

23.90 ± 7.76

46.68 ± 11.18

1.67

0.120

Passive Nursing

7.80 ± 2.67

5.66 ± 2.91

0.54

0.597

Licking Pups

7.37 ± 1.24

5.19 ± 1.48

1.13

0.281

Maternal Care was assessed hourly throughout exposure and for several hours following
exposure (as described in the methods). Key maternal behaviors were scored and
displayed above. DF = 12, n = 7.
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Figure 4.1: Characterization of the Exposure Paradigm
Pups were exposed to alcohol for 4 hours/day via vapor inhalation from P3 to P5. (A) Pups were
weighed daily and the average weight per pup was recorded (n = 3-12 litters). (B) Nursing ability
was quantified as the percentage of pups in each litter with milk visible in their stomachs each
morning prior to exposure (n = 5-6 litters). (C) Similar litter sizes were assigned to each treatment
group on P3 (n = 17 litters). (D) Pup blood alcohol concentrations (n = 4 pups from 4 litters) were
each measured at the beginning (0 hours), middle (2 hours), and end (4 hours) of the exposure,
as well as at several time points after. The green line represents the four hour exposure period.
Peak maternal BAC was assessed at 4 hours (n = 3 dams exposed after pups had been
weaned). (*** p < 0.001).

To determine if this PAE paradigm induced deficits in cerebellardependent behavior, rats were tested on a Catwalk apparatus and several
parameters for gait were analyzed as described in Table 4.2/Additional file 3.
Alterations in gait are associated with cerebellar impairment and particularly with
Purkinje cell dysfunction

273-275

. PAE had significant effects on many aspects of

gait (Table 4.3/Additional File 4, Fig. 4.2a-f), including phase dispersions
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between the LF→ LH paws (Fig. 4.2b, t(16) = 2.67, p = 0.017, unpaired t-test), the
RF→ RH paws (Fig. 4.2f, t(16) = 4.35, p = 0.0005, by unpaired t-test) and the
LF→ RF paws (Fig. 4.2e, t(16) = 2.21, p = 0.042, unpaired t-test), which are
determinants of inter-limb coordination. Of note, print positions, on both the right
(Fig. 4.2c, t(16) = 3.26, p = 0.005, by unpaired t-test) and left (Fig. 4.2d, t(16) =
2.66, p = 0.017, by unpaired t-test) sides of the body were affected after PAE. In
a normal gait, the hind paw makes contact with the walkway in nearly the same
location as the previous step of the forepaw on the same side of the body. In
PAE animals, the distance between placement of these paws was noticeably
increased (Fig. 4.2a). Spatial parameters related to individual paws such as print
area and intensity were unaffected by PAE (Table 4.3/Additional File 4).
Additionally, while PAE decreased the average speed of the animal, and the
swing(s) of the LF, it had no other effects on temporal parameters (Table
4.3/Additional File 4).
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Figure 4.2: Postnatal Alcohol Exposure (PAE) Induced Alterations in Gait and Deficits in
Fear Conditioning
(A-F) Animals aged P45-50 were placed on a Catwalk apparatus and differences in gait were
assessed (n = 9 animals from 4 litters). (A) Representative Catwalk images are shown illustrating
a PAE-induced reduction in overlap between the position of front and hind paws (LF =Left
Forepaw, LH = Left Hindpaw, RF = Right Forepaw, RH = Right Hindpaw). Summary graphs
illustrating the overall effect of PAE on the distance between placement of fore and hind paws on
the right (B) and left (C) side of the body were measured. (D-F) Phase dispersions, which are
indicators of inter-limb coordination, were measured between paws. (G-H) Animals aged P36-48
(n = 5-7 animals from 5-7 litters) were tested for performance on a variation of the fear
conditioning test in which they were pre-exposed to the context the day before being re-exposed
to the context and then shocked. (* p < 0.05, ** p < 0.01, *** p < 0.001)

To determine if PAE elicited any deficits in hippocampal-dependent
behavior, performance in the multiple pre-exposure contextual fear conditioning
test was assessed (Fig. 4.2g). PAE animals spent significantly less time freezing
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in response to the context in which they had previously received a foot shock
than control animals (Fig. 4.2h, t(10) = 4.64, p = 0.0009, unpaired t-test).

4.4.2 PAE Decreases Neuronal Number in the Cerebellar Vermis
On the morning after the first exposure (P4), no effect of PAE was
observed on Purkinje cell density across any of the lobule regions (Fig. 4.3a-b,
two-way ANOVA, interaction F(2,18) = 0.15, p = 0.859; lobule F(2,18) = 5.78, p =
0.012; alcohol F(1,18) = 0.28, p = 0.602). Similarly, thickness of the external
granule layer (EGL) was unaffected by PAE (Figure 4.11a/Additional file 1a, twoway ANOVA, interaction F(2,18) = 0.21, p = 0.816; lobule F(2,18) = 0.21, p = 0.031;
alcohol F(1,18) = 0.39, p = 0.538) as well as the internal granule layer (IGL, Figure
4.11b/Additional file 1b, two-way ANOVA, interaction F(2,18) = 0.20, p = 0.820;
lobule F(2,18) = 2.32, p = 0.127; alcohol F(1,18) = 1.93, p = 0.182). However, at the
end of exposure on P6, the alcohol exposed pups showed a dramatic reduction
in the number of Purkinje neurons present in the cerebellar vermis in all lobule
regions (Fig. 4.3c-d, two-way ANOVA, interaction F(2,18) = 0.83, p = 0.451; lobule
F(2,18) = 1.04, p = 0.375; alcohol F(1,18) = 68.81, p < 0.0001; Bonferroni post hoc
test: I-III, p < 0.0001; IV-VIII, p = 0.002; IX-X, p = 0.001). There was also an
overall decrease in thickness of the EGL (Figure 4.11c/Additional file 1c, two-way
ANOVA, interaction F(2,18) = 0.26, p = 0.776; lobule F(2,18) = 0.66, p = 0.527;
alcohol F(1,18) = 7.87, p = 0.012), although there was no significant effect in
individual lobule regions as measured by post-hoc analysis. Furthermore, IGL
thickness was not affected (Figure 4.11d/Additional file 1d, two-way ANOVA,
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interaction F(2,18) = 0.37, p = 0.694; lobule F(2,18) = 1.101, p = 0.354; alcohol
F(1,18) = 0.01, p = 0.912).
On P45, the number of Purkinje cells continued to be decreased in lobule
regions I-III and IX-X, but not in regions IV-VII (Fig. 4.3e-f, two-way ANOVA,
interaction F(2,18) = 9.24, p = 0.002; lobule F(2,18) = 0.55, p = 0.586; alcohol F(1,18)
= 28.00, p < 0.0001; Bonferroni post hoc test: I-III p = 0.001; IX-X p = 0.0002).
These findings are consistent with previous studies showing lobules IV-VIII to be
less sensitive to PAE

53

. Interestingly, granule cell layer thickness was no longer

affected at P45 (Figure 4.11e/Additional file 1e, two-way ANOVA, interaction
F(2,18) = 1.16, p = 0.337; lobule F(2,18) = 1.664, p = 0.217; alcohol F(1,18) = 0.08, p
= 0.774), indicating that PAE induces long-term selective loss of Purkinje
neurons.
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Figure 4.3: Postnatal Alcohol Exposure (PAE) Reduced the Number of Purkinje Neurons in
the Cerebellar Vermis
Representative images of the cerebellar vermis stained for calbindin (red) to label Purkinje
neurons and 4’,6-diamidino-2-phenylindole (DAPI, blue) to label cell nuclei. Purkinje cell density
was quantified during the first withdrawal period on P4 (A-B), the third withdrawal period on P6
(C-D) (see top panel in Fig 4.4) and also on P45 (E-F). The cerebellar vermis was divided into
three lobule regions and quantified separately. The Purkinje cell layer (PCL) was traced as shown
and the number of Purkinje cells within were counted. (** p < 0.01, **** p < 0.0001). n = 4 animals
from 4 litters. The thickness of the external and internal granule cell layers (EGL and IGL,
respectively) was also quantified and results are shown in Fig 4.11). Scale bars are 40 µm and 10
µm for low and high magnification images, respectively.

4.4.3 PAE Increases Cytokine Expression in the Cerebellar Vermis during
Periods of Withdrawal
To determine how the neuroimmune response evolves as a function of
multiple exposures, pro- and anti-inflammatory cytokine responses were
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measured by RT-PCR throughout the exposure. PAE increased the expression
of pro-inflammatory IL-1β during withdrawal periods on P4 and P6 (Fig. 4.4a,
two-way ANOVA, interaction F(4,70) = 1.34, p = 0.265; age F(4,70) = 4.72, p =
0.002; alcohol F(1,70) = 20.65, p < 0.0001; Bonferroni post hoc test for PAE: P4 p
= 0.045; P6 p = 0.002). Similarly, TNFα expression was increased on P4 (Fig.
4.4b, two-way ANOVA, interaction F(4,70) = 5.70, p = 0.0005; age F(4,70) = 5.66, p
= 0.0005; alcohol F(1,70) = 14.06, p = 0.0004; Bonferroni post hoc test for PAE:
P4 p < 0.0001). Additionally, PAE significantly increased overall expression of
anti-inflammatory cytokines TGFβ (Fig. 4.4c, two way ANOVA, interaction F(4,69)
= 0.95, p = 0.442; age F(4,69) = 0.73, p = 0.577; alcohol F(1,69) = 12.24, p =
0.0008) and IL10 (Fig. 4.4d, two way ANOVA, interaction F(4,70) = 0.88, p =
0.481; age F(4,70) = 2.71, p = 0.037; alcohol F(1,70) = 4.17, p = 0.045). However,
expression was not found to be significantly elevated by post-hoc test on any
individual postnatal day.
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Figure 4.4: Postnatal Alcohol Exposure (PAE) Increases Cytokine Expression in the
Cerebellar Vermis
Effect of PAE on interleukin-1β (IL-1β, A), tumor necrosis factor α (TNFα, B), transforming growth
factor β (TGFβ, C) and interleukin-10 (IL10, D) in the cerebellar vermis. Animals were exposed to
alcohol from P3-5 for 4 hours daily (10 AM to 2 PM, represented by green lines in top panel).
Expression of cytokines was measured by RT-PCR throughout the exposure. Time points during
peak blood alcohol levels were collected on P3 (I) and P5 (III). Time points during withdrawal
periods were collected on P4 (II) and P6 (IV) and are also indicated by grey shading in panels AD. For more details on the timecourse of the blood alcohol concentrations, please see Fig 4.1D.
To address if effects were persistent, P11-13 was also included. Threshold cycle values (CT)
were normalized to hypoxanthine phosphoribosyltransferase 1(HPRT1) and each individual value
was normalized with respect to the average of the P3 air controls (see Materials and Methods). (*
p < 0.05, ** p < 0.01, **** p < 0.0001). n = 8 animals from 8 litters.
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4.4.4 PAE Induces Morphological Changes in Microglia and Increases
Astrocytic GFAP Expression in the Cerebellar Vermis
To determine if the increase in cytokine levels is associated with
alterations in glial cells, we stained for the microglia marker IBA-1 and the
astrocyte marker GFAP. During the first withdrawal period (P4), the majority of
microglia existed in a transitional state, with none exhibiting a ramified/resting
morphology. However, microglia in PAE animals appeared very similar to those
in controls (Fig. 4.5a-c). The proportion of microglia in each morphological state
was not altered by PAE (Fig. 4.5b, two-way ANOVA, interaction F(3,24) = 2.0, p =
0.141; morphology F(3,24) = 124.2, p < 0.0001; alcohol F(1,24) = 9.17e-12, p >
0.9999) and there was no increase in amoeboid morphology across the lobule
regions (Fig. 4.5c, two-way ANOVA, interaction F(2,18) = 0.09, p = 0.911; lobule
F(2,18) = 0.57, p = 0.574; alcohol F(1,18) = 1.53, p = 0.232).
By the end of the exposure paradigm, during the third withdrawal period
(P6), while most microglia in control animals continued to exhibit a transitional
morphology, PAE animals had a significantly elevated presence of amoeboid
microglia in the cerebellar vermis and a subsequent decrease in the number of
microglia in the transitional 1 (T1) morphology (Fig. 4.5d, e, two-way ANOVA,
interaction F(3,24) = 11.69, p < 0.0001; morphology F(3,24) = 19.69, p < 0.0001;
alcohol F(1,24) = 1.81e-13, p > 0.999; Bonferroni post hoc test: amoeboid cells p =
0.0004; T1 cells p = 0.008). Similarly, the proportion of microglia in the amoeboid
morphology was significantly increased in lobule regions IV-VIII and IX-X, but not
in lobule region I-III (Fig. 4.5f, two-way ANOVA, interaction F(2,18) = 0.73, p =
0.496; lobule F(2,18) = 0.51, p = 0.609; alcohol F(1,18) = 30.24, p < 0.0001;
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Bonferroni post hoc test: IV-VIII p = 0.002; IX-X p = 0.024). Since the majority of
microglia were located within the center of the lobules, rather than in the PCL
where neurodegeneration occurred, we used a neurofilament stain to investigate
the possibility that amoeboid microglia were directly damaging neuronal axons
which exist in this area in adult animals. However, neurofilament staining showed
little presence of neuronal axons extending into this region by P6. Additionally, no
difference was seen in the intensity of neurofilament staining between PAE and
control animals in any lobule region (Figure 4.12/Additional file 2, two-way
ANOVA, interaction F(2,18) = 0.34, p = 0.72; lobule F(2,18) = 0.94, p = 0.410;
alcohol F(1,18) = 3.83, p = 0.066)
To investigate if changes in microglial morphology persist, staining was
also assessed on P45. By this age, nearly all microglia in both PAE and control
animals existed in a resting state and there was no interaction between treatment
and morphology (Fig. 4.5g, h, two-way ANOVA, interaction F(3,24) = 1.33, p =
0.289; morphology F(3,24) = 10612, p < 0.0001; alcohol F(1,24) = 1.87e-10, p >
0.999). Similarly, there was no effect of PAE on the proportion of microglia in a
resting morphology across lobule regions (Fig. 4.5i, two-way ANOVA, interaction
F(2,18) = 0.47, p = 0.633; lobule F(2,18) = 0.36, p = 0.706; alcohol F(1,18) = 0.79, p =
0.385).
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Figure 4.5: Postnatal Alcohol Exposure (PAE) Activates Microglia in the Cerebellar Vermis
Representative images of the cerebellar vermis are stained for ionized calcium-binding adapter
protein molecule 1 (IBA-1, red) to label microglia and 4’,6-diamidino-2-phenylindole (DAPI, blue)
to label cell nuclei. Microglial morphology was quantified as resting, transitional 1 (T1),
transitional 2 (T2), or amoeboid as shown in the top right panel. The proportion of microglia
exhibiting each morphology was quantified during the first withdrawal period on P4 (A-B), the third
withdrawal period on P6 (D-E) (see top panel in Fig. 4.4), and also on P45 (G-H). To investigate
regional differences, the cerebellar vermis was divided into three lobule regions and the
proportion of microglia in an amoeboid morphology was quantified in each region on P4 (C) and
P6 (F). On P45 (I) the proportion of resting microglia was quantified by region as there were no
amoeboid microglia. (* p < 0.05, ** p < 0.01, *** p < 0.001). n = 4 animals from 4 litters. Scale
bars are 40 µm and 10 µm for representative low and high magnification images, respectively.
The yellow labels represent the external granule cell (EGL), Purkinje cell (PCL) and Internal
Granule Cell (IGL) layers.

To examine astrocytes, changes in GFAP intensity were measured in the
EGL, PCL, and IGL of the lobules. During the first withdrawal period (P4), PAE
caused an overall significant increase in GFAP expression in the EGL (Fig. 4.6a,
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b, two-way ANOVA, interaction F(2,18) = 0.05, p = 0.954; lobule F(2, 18) = 3.70, p =
0.045; alcohol F(1,18) = 15.59, p = 0.001) and the PCL (Fig. 6a, c, two-way
ANOVA, interaction F(2,18) = 0.21, p = 0.817; lobule F(2,18) = 4.34, p = 0.029;
alcohol

F(1,18) = 8.55, p = 0.009) of the cerebellar vermis, but not in any

individual lobule region by post hoc test. In the IGL, GFAP expression was
significantly increased in lobule regions I-III (Fig. 4.6a, d, two-way ANOVA,
interaction F(2,18) = 0.44, p = 0.649; lobule F(2,18) = 1.87, p = 0.182; alcohol F(1,18)
= 14.21, p = 0.001; Bonferroni post hoc test: p = 0.039).
By the end of the exposure paradigm, during the third withdrawal period
(P6), post-hoc analysis showed that PAE increased astrocytic GFAP expression
across all three lobule regions in the EGL (Fig. 4.6e, f, two-way ANOVA,
interaction F(2,18) = 0.01, p = 0.987; lobule F(2,18) = 0.06, p = 0.938; alcohol F(1,18)
= 25.61, p < 0.0001; Bonferroni post hoc test: I-III p = 0.022; IV-VIII p = 0.027; IXX p = 0.035), the PCL (Fig. 4.6e, g, two-way ANOVA, interaction F(2,18) = 0.21, p
= 0.812; lobule F(2,18) = 0.49, p = 0.620; alcohol F(1,18) = 27.97, p < 0.0001;
Bonferroni post hoc test: I-III p = 0.007; IV-VIII p = 0.025; IX-X p = 0.049), and in
the IGL (Fig. 4.6e, h, two-way ANOVA, interaction F(2,18) = 0.00, p = 0.998; lobule
F(2,18) = 0.22, p = 0.803; alcohol F(1,18) = 37.33, p < 0.0001; Bonferroni post hoc
test: I-III p = 0.008; IV-VIII p = 0.007; IX-X p = 0.007). On P45, PAE no longer
increased GFAP expression in either the ML (Fig. 4.6i, j, two-way ANOVA,
interaction F(2,18) = 0.01, p = 0.988; lobule F(2,18) = 0.12, p = 0.884; alcohol F(1,18)
= 2.83, p = 0.110) or the GCL (Fig. 4.6i, k, two-way ANOVA, interaction F(2,18) =
0.16, p = 0.852; lobule F(2,18) = 0.07, p = 0.934; alcohol F(1,18) = 4.19, p = 0.056).
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Figure 4.6: Postnatal Alcohol Exposure (PAE) Increases Astrocytic Glial Fibrillary Acidic
Protein (GFAP) Expression in the Cerebellar Vermis
Representative images of the cerebellar vermis are stained for GFAP (red) to label astrocytes
and 4’,6-diamidino-2-phenylindole (DAPI, blue) to label cell nuclei. The cerebellar vermis was
divided into three lobule regions and quantified separately during the first withdrawal period on P4
(A-D), the third withdrawal period on P6 (E-H) (see top panel in Fig. 4.4) and also on P45 (I-K).
On P4 and P6 the external granule layer (EGL), Purkinje cell layer (PCL), and internal granule
layer (IGL) of each lobule were traced as shown. On P45 the molecular layer (ML) and granule
cell layer (GCL) of each lobule were traced (the EGL is no longer present at this age). GFAP
intensity levels were measured within each layer. (* p < 0.05, ** p < 0.01). n = 4 animals from 4
litters. Scale bars are 40 µm and 10 µm for low and high magnification images, respectively.

4.4.5 PAE Does Not Reduce the Number of Granule Cells or Pyramidal
Neurons in the Hippocampal Formation
To investigate potential regional differences in the effects of PAE, the
hippocampal formation was also analyzed for neuronal loss in the GCL of the DG
and in the pyramidal cell layer of the CA1 and CA3 subregions. During the first
withdrawal period (P4), PAE animals exhibited no difference in neuronal
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densities within the respective subregions (Fig. 4.7a, b, two-way ANOVA,
interaction F(2,18) = 0.44, p = 0.650; region F(2,18) = 28.28, p < 0.0001; alcohol
F(1,18) = 2.13, p = 0.162) as well as similar cell layer thicknesses (Fig. 4.7a, c,
two-way ANOVA, interaction F(2,18) = 1.21, p = 0.322; region F(2,18) = 47.25, p <
0.0001; alcohol F(1,18) = 1.66, p = 0.214). Additionally, at the end of the exposure
paradigm, during the third withdrawal period (P6), PAE animals showed no
change in neuronal density in any subregion (Fig. 4.7d, e, two-way ANOVA,
interaction F(2,18) = 0.00, p = 0.999; region F(2,18) = 6.39, p = 0.008; alcohol F(1,18)
= 1.47, p = 0.240) nor were there any differences in cell layer thicknesses (Fig.
4.7d, f, two-way ANOVA, interaction F(2,18) = 1.30, p = 0.297; region F(2,18) =
68.30, p < 0.0001; alcohol F(1,18) = 0.17, p = 0.685).
Similarly, on P45 there was no significant change in either neuronal
density (Fig. 4.7g, h, two-way ANOVA, interaction F(2,18) = 0.13, p = 0.878; region
F(2,18) = 12.73, p = 0.0004; alcohol F(1,18) = 3.38, p = 0.082) or cell layer
thicknesses (Fig. 4.7g, i, two-way ANOVA, interaction F(2,18) = 2.48, p = 0.112;
region F(2,18) = 109.2, p < 0.0001; alcohol F(1,18) = 0.32, p = 0.579).
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Figure 4.7: Postnatal Alcohol Exposure (PAE) Does not Alter the Number of Pyramidal
Neurons in the Hippocampus
Representative images of the hippocampus are stained for NeuN (red) to label neurons and 4’,6diamidino-2-phenylindole (DAPI, blue) to label cell nuclei during the first withdrawal period on P4
(A-C), the third withdrawal period on P6 (D-F) (see top panel in Fig. 4) and also on P45 (G-I).
2
Cells were counted within 30 um areas in the stratum pyramidale (SP) layer of the CA3 and
CA1, and in the granule cell layer (GCL) of the dentate gyrus (DG) subregion. Thickness of the
cell layers was also measured. n = 4 animals from 4 litters. Scale bars are 40 µm and 10 µm for
representative images and high magnification pictures, respectively.

4.4.6 PAE Increases Cytokine Expression in the Hippocampus
To compare the neuroimmune response in the hippocampus with the
cerebellar vermis, pro- and anti-inflammatory cytokines were measured by RTPCR throughout the exposure. PAE had no effect on the expression of proinflammatory IL-1β (Fig. 4.8a, two-way ANOVA, interaction F(4,69) = 1.55, p =
0.197; age F(4,69) = 1.61, p = 0.183; alcohol F(1,69) = 2.21, p = 0.142).
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Conversely, there was a significant interaction between PAE and TNFα
expression, and post-hoc analysis revealed an increase during the first
withdrawal period on P4 (Fig. 4.8b, two-way ANOVA, interaction F(4,69) = 3.30, p
= 0.016; age F(4,69) = 1.81, p = 0.137; alcohol F(1,69) = 2.45, p = 0.122; Bonferroni
post hoc test: P4 p = 0.005). Consistent with findings in the cerebellum, TNFα
expression was not significantly elevated by post-hoc analysis the following day
during peak BAC (P5). PAE did not affect expression of anti-inflammatory TGFβ
(Fig. 4.8c, two-way ANOVA, interaction F(4,69) = 1.78, p = 0.142; age F(4,69) =
0.97, p = 0.431; alcohol F(1,69) = 0.95, p = 0.334). In contrast, PAE increased
overall expression of anti-inflammatory IL10 (Fig. 4.8d, two-way ANOVA,
interaction F(4,69) = 1.76, p = 0.147; age F(4,69) = 2.03, p = 0.100; alcohol F(1,69) =
6.00, p = 0.017), but not on any individual day as assessed by post-hoc analysis.
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Figure 4.8: Postnatal Alcohol Exposure (PAE) Increases Cytokine Expression in the
Hippocampus
Effect of PAE on interleukin-1β (IL-1β, A), tumor necrosis factor α (TNFα, B), transforming growth
factor β (TGFβ, C) and interleukin-10 (IL10, D) in the hippocampus. Animals were exposed to
alcohol from P3-5 for 4 hours daily (10 AM to 2 PM, represented by green lines). Expression of
cytokines was measured by RT-PCR throughout the exposure. Time points during peak blood
alcohol levels were collected on P3 (I) and P5 (III). Time points during withdrawal periods were
collected on P4 (II) and P6 (IV) and are also indicated by grey shading in panels A-D. For more
details on the timecourse of the blood alcohol concentrations, please see Fig. 4.1D. To address if
effects were persistent, P11-13 was also included. Threshold cycle values (CT) were normalized
to hypoxanthine phosphoribosyltransferase 1(HPRT1) and each individual value was normalized
with respect to the average of the P3 air controls (see Materials and Methods). . (** p < 0.01). n =
8 animals from 8 litters.

4.4.7 PAE Increases Astrocytic GFAP Expression in the Hippocampus
To assess morphological changes in glial cells in the hippocampus,
astrocytes and microglia were stained with GFAP and IBA-1, respectively. During
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the first withdrawal period (P4), the majority of microglia exhibited a T1
morphology and there was no interaction between PAE and morphology (Fig.
4.9a, two-way ANOVA, interaction F(3,24) = 0.16, p = 0.924; morphology F(3,24) =
59.46, p < 0.0001; alcohol F(1,24) = 0.0, p > 0.999). By the third withdrawal period
(P6), the majority of microglia in both groups exhibited a more mature,
resting/ramified morphology, but there was a significant interaction between PAE
and morphology, and post-hoc analysis revealed a decrease in the proportion of
microglia in a resting morphology (Fig. 4.9b, two-way ANOVA, interaction F(3,24)
= 4.21, p = 0.016; morphology F(3,24) = 145.7, p < 0.0001; alcohol F(1,24) = 2.87e11, p > 0.999; Bonferroni post hoc test: resting cells p = 0.021). However, PAE
did not significantly increase the number of microglia in T1, T2, or amoeboid
forms. Finally, on P45 no differences in microglial morphology were evident in the
hippocampus of PAE animals (Fig. 4.9c, two-way ANOVA, interaction F(3,24) =
1.31, p = 0.295; morphology F(3,24) = 35, p < 0.0001; alcohol F(1,24) = 0.0, p >
0.999) and nearly all microglia in both groups were in a resting morphological
state.
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Figure 4.9: Postnatal Alcohol Exposure (PAE) Decreases Resting Microglia on P6
The effect of PAE on microglial morphology in the hippocampus during the first withdrawal period
on P4 (A), the third withdrawal period on P6 (B) (see top panel in Fig. 4.4) and also on P45 (C).
Representative images of the hippocampus are stained for ionized calcium-binding adapter
protein molecule 1(IBA-1, red) to label microglia and 4’,6-diamidino-2-phenylindole (DAPI, blue)
to label cell nuclei. Microglial morphology was quantified as resting, transitional 1 (T1), transitional
2 (T2), or amoeboid as shown in Fig. 4.5. The proportion of microglia exhibiting each morphology
was quantified. Since no significant differences were found in activation, morphology by region
was not analyzed. Asterisks represent significance by post-hoc test. (* p < 0.05). n = 4 animals
from 4 litters. Scale bars are 40 µm and 10 µm for low and high magnification images,
respectively. Stratum pyramidale (SP) of the CA1 region and the granule cell layer (GCL) of the
dentate gyrus (DG) are labeled in the images.

In the CA1 and CA3 subregions, changes in GFAP intensity were
quantified within the stratum oriens (SO), SP, and either within the stratum
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radiatum (SR), and stratum lacunosum moleculare (SLM) or the stratum lucidum
(SL) and SR/SLM, respectively.. Similarly, the molecular layer (ML), GCL, and
hilus were traced in the DG subregion and GFAP intensity was quantified. During
the first withdrawal period (P4), PAE did not increase GFAP expression in the
DG (Fig. 4.10a,b, two-way ANOVA, interaction F(2,18) = 0.28, p = 0.760; layer
F(2,18) = 1.17, p = 0.334; alcohol F(1,18) = 1.16, p = 0.295), CA3 (Fig. 4.10a,c, twoway ANOVA, interaction F(3,24) = 0.06, p = 0.979; layer F(3,24) = 2.99, p = 0.051;
alcohol F(1,24) = 0.83, p = 0.371), or the CA1 subregion (Fig. 4.10a, d, two-way
ANOVA, interaction F(3,24) = 0.05, p = 0.986; layer F(3,24) = 10.51, p = 0.0001;
alcohol F(1,24) = 0.81, p = 0.378).
By the third withdrawal period on P6, astrocyte activation was evident in
the DG subregion in the ML and the hilus (Fig. 4.10e, f, two-way ANOVA,
interaction F(2,18) = 1.42, p = 0.267; layer F(2,18) = 9.03, p = 0.002; alcohol F(1,18)
= 28.42, p < 0.0001; Bonferroni post hoc test: ML p = 0.002; hilus p = 0.014).
Similarly, the CA3 subregion exhibited increased GFAP expression in the SO,
SL, and SR/SLM layers (Fig. 4.10e, g, two-way ANOVA, interaction F(3,24) = 0.89,
p = 0.460; layer F(3,24) = 17.76, p < 0.0001; alcohol F(1,24) = 49.81, p < 0.0001;
Bonferroni post hoc test: SO p = 0.006; SL p = 0.011; SR/SLM p = 0.0003).
Additionally, in the CA1, the SO, SR, and SLM exhibited increased GFAP
expression (Fig. 4.10e, h, two-way ANOVA, interaction F(3,24) = 1.47, p = 0.247;
layer F(3,24) = 17.38, p < 0.0001; alcohol F(1,24) = 44.65, p < 0.0001; Bonferroni
post hoc test: SO p = 0.001; SR p = 0.048; SLM p = 0.0007). Of note, the SP in
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the CA3 and CA1 and the GCL in the DG did not show significant increases in
GFAP expression.
On P45, there was a significant overall increase in GFAP expression in
the DG (Fig. 4.10i, j, two-way ANOVA, interaction F(2,18) = 0.54, p = 0.591; layer
F(2,18) = 6.92, p = 0.006; alcohol F(1,18) = 5.70, p = 0.028) and CA3 (Fig. 4.10 i,k,
two-way ANOVA, interaction F(3,24) = 0.11, p = 0.953; layer F(3,24) = 0.84, p =
0.487; alcohol F(1,24) = 11.35, p = 0.003) subregions, although post-hoc analysis
indicated that no individual layers exhibited a significant increase. Additionally, no
increase was found in the CA1 subregion (Fig. 4.10i, l, two-way ANOVA,
interaction F(3,24) = 0.26, p = 0.854; layer F(3,24) = 3.10, p = 0.046; alcohol F(1,24)
= 1.73, p = 0.201).
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Figure 4.10: Postnatal Alcohol Exposure (PAE) Increases Astrocytic Glial Fibrillary Acidic
Protein (GFAP) Expression in the Hippocampus
Representative images of the hippocampus are stained for GFAP (red) to label astrocytes and
4’,6-diamidino-2-phenylindole (DAPI, blue) to label cell nuclei during the first withdrawal period on
P4 (A-D), the third withdrawal period on P6 (E-H) (see top panel in Fig. 4.4), and also on P45 (IL). The CA1 and CA3 subregions the stratum oriens (SO), stratum pyramidale (SP) and either the
stratum radiatum (SR), and stratum lacunosum moleculare (SLM) layers or the stratum lucidum
(SL), respectively, were traced and GFAP intensity was quantified within. In the dentate gyrus
(DG), the molecular layer (ML), granule cell layer (GCL), and hilus were quantified. (* p < 0.05, **
p < 0.01, *** p < 0.001). n = 4 animals from 4 litters. Scale bars are 40 µm and 10 µm for low and
high magnification images, respectively. SP of the CA1 region and the GCL of the DG are
labeled in the images.
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4.5 Discussion
This study is the first to perform a comprehensive investigation of
neuroinflammation throughout multiple alcohol exposure and withdrawal
episodes during the third trimester-equivalent period of development. We report
findings that complement earlier studies on the effects of PAE on the
neuroimmune system. Specifically, we find vast differences in the hippocampus
and cerebellar vermis with respect to cytokine production, neuronal loss, and glial
cell activation. We report that signs of both microglial and astrocyte activation
occurred in parallel with neurodegeneration in the cerebellar vermis and with gait
disturbances, while in the hippocampus indications of astrocyte activation was
evident in conjunction with spatial memory alterations. Intriguingly, at no
measured point in the cerebellar vermis was there significant microglial presence
within the Purkinje cell layer, where the majority of cell death transpired.
Additionally, PAE increased cytokine expression in both brain regions, albeit to a
lesser extent in the hippocampus. Interestingly, we find that, rather than building
with subsequent exposures, cytokine production is transiently increased during
withdrawal periods and a different response is elicited after one binge episode
compared to three. The cytokines produced in this model were primarily proinflammatory, with only minor elevations in anti-inflammatory cytokines, and
increases in either pathway were not long-lasting.
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4.5.1 Increased mRNA Expression of Pro-inflammatory Cytokines Occurs in
the Hippocampus and Cerebellar Vermis, but Only during Periods of
Withdrawal
In the hippocampus and cerebellar vermis, we confirm that PAE stimulates
production of pro-inflammatory cytokines. Surprisingly, cytokine production did
not escalate as a function of exposure, but rather spiked during periods of
withdrawal and dropped off when BACs were at peak levels at the end of 4 hour
exposure periods. Withdrawal from alcohol is associated with processes known
to stimulate neuroinflammation, such as excitotoxicity278, prevention of which has
been shown to alleviate behavioral deficits in a PAE model
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. Furthermore,

withdrawal from binge exposure increases the number of microglia in adult rat
brains280. As such, it is likely that withdrawal, rather than alcohol itself, directly
contributes to cytokine production in the developing brain, although we cannot
discount the possibility that this is in part explained by a delayed onset of
cytokine production induced by alcohol exposure.
Additionally, it has been suggested that anti-inflammatory cytokines
contribute to the alcohol-induced neuroimmune response in adults181. To this
end, we included anti-inflammatory cytokines in our analysis. While small
increases were seen in TGFβ and IL10 in the cerebellar vermis and
hippocampus, respectively, the majority of cytokine production was proinflammatory. However, anti-inflammatory cytokines could be responsible for the
diminished pro-inflammatory response over the course of the paradigm as both
TGFβ and IL10 can blunt the production of pro-inflammatory cytokines116,281,282.
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Our findings in the cerebellar vermis are consistent with previous
observations that just one day of heavy PAE can increase levels of IL-1β in this
region, and that multiple days of exposure amplifies this effect210. Interestingly,
while we also found TNFα expression to be elevated during the first withdrawal
period, levels were not significantly above those in control animals after three
withdrawal periods. This suggests that, in this case, the IL-1β and TNFα
activation pathways are differentially affected. It is also possible that if antiinflammatory cytokines are influencing pro-inflammatory cytokine expression as
described above, they could elicit a greater effect on TNFα expression.
While the exact mechanism by which alcohol activates the neuroimmune
system is not fully understood, particularly in the context of developmental
exposure, studies in adults have shown that alcohol likely activates microglia
through toll-like receptor 4185. Moreover, alcohol exposure can increase secretion
of the endogenous cytokine high mobility box 1 (HMGB1) by neurons and other
cells189. HMGB1 then activates toll-like receptor 4, expressed on microglia, and
induces cytokine secretion in a positive feedback loop. It is possible that the
mechanism for microglial activation by alcohol in the developing brain is similar.

4.5.2 Regional Differences between the Hippocampus and Cerebellar
Vermis may be a Result of the Window of Exposure
Specific brain regions are susceptible to alcohol-induced damage,
particularly neuronal loss, only during limited developmental windows. In the
cerebellum, Purkinje cell loss is associated with exposure on P5 or before, but
not later70,72,73, while the hippocampus is more resistant to cell loss during this
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period44,45. Therefore, our exposure paradigm (P3-5) was expected to more
heavily affect cells in the cerebellar vermis. In support of this, we saw no signs of
neuronal loss in the hippocampus, but massive Purkinje cell loss in the cerebellar
vermis on P6. This loss was still evident on P45, although to a lesser extent.
There was also a decrease in Purkinje cell density on P45 compared to P4 and
P6, likely due to the period of programmed cell death that occurs in the early
postnatal period283, as well as the expanding overall area of the cerebellum
during development.
In the hippocampus, pro-inflammatory cytokine production was not as
robust as in the cerebellar vermis. Of the cytokines measured, TNFα was the
only one significantly increased on a specific day of the paradigm, and only in the
first withdrawal period. These observations challenge previous findings showing
dramatically escalated levels of both pro- and anti-inflammatory cytokines in the
hippocampus several weeks after exposure212. They also contrast with studies
finding elevated levels of both TNFα and IL-1β in the hippocampus during
withdrawal, 24 hours after a P4-9 PAE paradigm208. However, in both cases
these discrepancies could be explained by differences in the method of
administration (oral gavage versus vapor inhalation), rodent strain or type, the
kind of sample collected (mRNA versus protein), and, in particular, the longer
duration of the exposure paradigm. While our study specifically included a time
window during which alcohol exposure more highly affects the cerebellum, the
hippocampus has been shown to be more vulnerable to alcohol at a slightly later
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postnatal time point42,277,284,285, which overlap with the exposure paradigms used
in the studies described above.
Another important aspect of the timing of alcohol exposure, as it pertains
to regional susceptibility, is the maturation rate of the neuroimmune system.
During the early postnatal period, microglia mature faster from an amoeboid
(activated) state to a branched (resting) morphological state in the hippocampus
than in the cerebellum166. Indeed, we found that microglia in the hippocampus
exhibited a more mature phenotype on P4 and P6 than those in the cerebellar
vermis. Microglia that are amoeboid or in the early stages of transition could be
primed to overreact to insult163, explaining the alcohol-induced increase in
cytokine production in the cerebellar vermis, when compared to the
hippocampus. Additionally, in agreement with previous studies208,209, by the end
of our PAE paradigm, we observed a dramatic increase in the proportion of
microglia in an amoeboid morphology in the cerebellar vermis, consistent with
microglia activation. Conversely, we saw little sign that microglia were
transitioning to a morphology associated with activation within the hippocampus.
This is in contrast with observations in other models of PAE utilizing a longer
exposure window that overlaps with hippocampal vulnerability208. Again, this is
likely due to temporal differences in regional susceptibility and the maturation
rate of microglia. These findings highlight the importance of considering the
window of exposure when anticipating the effects of PAE on the neuroimmune
system.
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4.5.3 PAE-Induced Increases in Astrocytic GFAP Expression Occur with or
without Microglial Morphological Transitions: Possible Relationships to
Neurodegeneration
As stated above, neuronal loss was seen with this paradigm in the
cerebellar vermis, but not in the hippocampus. Interestingly, an increase in
amoeboid microglia occurred only in the cerebellar vermis, while robust
elevations in astrocytic GFAP expression was observed in both brain regions.
While microglial morphological transitions and increased astrocytic GFAP
expression do not always equate to activation, they provide considerable
evidence of neuroinflammation and are highly associated with reactive glial cell
functions78,286-288. Based on this, our findings support the idea that microglial
activation is strongly associated with PAE-induced neuronal loss; however,
whether microglial activation contributes to or is caused by it remains unclear. In
support of the latter, there was little presence of microglia, amoeboid or
otherwise, in or near the cell layer in which neurodegeneration occurred.
However, it is possible that secreted factors, such as cytokines, could diffuse
from a distance to directly affect Purkinje cell soma or damage the axons of
these neurons, ultimately leading to neurodegeneration. Cytokine secretion did
precede neuronal loss in the cerebellar vermis, although there were no signs of
neuronal loss in the hippocampus, which also had significantly elevated levels of
TNFα on P4.
Similarly reactive astrocytes were observed alongside neuronal loss and
microglial morphological changes in the cerebellar vermis. However, unlike
microglia, there was a robust increase in astrocytic GFAP expression in the PCL,
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where neurodegeneration occurred. Although this increase was not markedly
higher than in the other cell layers. Importantly, signs of astrocyte activation were
also evident in the hippocampus, where there was no neuronal loss and little
indication of microglial activation. In this brain region, the increase in astrocytic
GFAP expression was lowest surrounding neuron somata. Taken together, these
findings indicate that astrocytes contribute to the effects of PAE in a brain regionspecific manner.
Astrocyte activation varies heavily based on the type of insult and
neighboring environmental cues137. As such, it is likely that astrocytes in the
hippocampus and cerebellar vermis have distinct functions. In some cases,
astrocytes can be heavily anti-inflammatory, can restrict migration of local and
peripheral inflammatory cells, and can secrete growth factors. Conversely,
astrocytes can also have pro-inflammatory functions including secretion of IL-1β
and TNFα137. Moreover, astrocytes have been shown to regulate microglial
activation139. It is possible that astrocyte activation in the hippocampus prevents
microglial activation and subsequent neuronal loss. Indeed, astrocytes have
been shown to have many positive effects on neurons after alcohol exposure in
cell culture and in-vivo prenatal models289-291. For instance, as astrocytes are
often strongly associated with increased neuronal survival292,293, they could also
be directly preventing neuronal loss.
Finally, we cannot discount the possibility that there is some contribution
by invading peripheral immune cells, such as macrophages. Astrocyte activation,
as seen in this model, can be indicative of astrocytic scars, which can block
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migration of peripheral immune cells137. However, the blood brain barrier is not
fully formed during the early postnatal period294 making it easier for peripheral
cells to infiltrate the brain. Additionally, increased levels of pro-inflammatory
cytokines, such as those seen in this model, can recruit peripheral immune
cells295 and future studies should address this possibility.

4.5.4 PAE Results in Deficits in both Hippocampal and CerebellarDependent Behavior
PAE animals exhibited deficits in contextual fear conditioning, which is
hippocampal dependent296,297. Although we did not see signs of neuronal loss in
the hippocampus, previous studies have identified several other mechanisms of
PAE-induced damage in this brain region, including alterations in synaptic
plasticity and transmission35,243, which could contribute to the observed deficit.
Interestingly, both of these processes have been shown to be affected by
TNFα298-300 which we found to be up-regulated in the hippocampus of PAE rats.
Therefore, neuroinflammation could be causing hippocampal-dependent deficits
through more subtle alterations, rather than through cell loss.
Additionally, PAE animals had significant alterations in gait. While gait has
been shown to be highly dependent on the cerebellum and particularly on
Purkinje cells274,275, it is also affected in other types of neurodegenerative
diseases that have more widespread effects in the brain276,301,302. Therefore,
while it is likely that PAE-induced Purkinje cell loss heavily impacts gait in these
animals, this paradigm may also cause damage to other structures, such as
descending spinal pathways or motor cortex, which could further contribute to
116

alterations in gait. Whether or not neuroinflammation is directly contributing to
these deficits remains unclear as the nature of the relationship between
neuroimmune activation and neuronal damage/loss requires further research.

4.5.5 Overall Conclusions
In summary, this study provides information that fills the following gaps in
knowledge

within

this

field:

1)

that

PAE

induces

neurodegeneration,

neurobehavioral deficits, and neuroimmune activation in a region- and timespecific manner rather than globally; 2) that cytokine secretion in response to
PAE is primarily pro-inflammatory and transient, mainly occurring during alcohol
withdrawal periods; and 3) that not only microglia, but also astrocytes, are
important participants in the neuroinflammatory response to developmental
alcohol exposure. Future work should investigate the mechanisms underlying
these region- and time-specific effects of PAE, as well as the potential utility of
anti-inflammatory agents in the treatment of FASDs.
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4.7 Additional Files

Figure 4.11: (Additional File 1) Postnatal Alcohol Exposure (PAE) does not Affect Granule
Cell Layer Thickness in the Cerebellar Vermis
Effect of PAE on external granule layer (EGL) and internal granule layer (IGL) thickness in the
cerebellar vermis during the first withdrawal period on P4 (a-b), the third withdrawal period on P6
(c-d) (see top panel in Fig. 4.4) and also on P45 (e). Animals were treated as described in Fig.
4.1. To investigate regional difference, lobules I-X of the cerebellar vermis were grouped into
three lobule regions and quantified separately. For sample images see Fig. 4.3. n = 4 animals
from 4 litters.
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Figure 4.12: (Additional File 2) Postnatal Alcohol Exposure (PAE) does not Affect
Neurofilament Levels in the Cerebellar Vermis
Effect of PAE on neurofilament in the cerebellar vermis during the third withdrawal period on P6
(see top panel in Fig. 4.4). Animals were treated as described in Fig. 4.1. Representative images
of the cerebellar vermis are stained for neurofilament (red) to label axons and 4’,6-diamidino-2phenylindole (DAPI, blue) to label cell nuclei. To investigate regional difference, lobules I-X of the
cerebellar vermis were grouped into three lobule regions and neurofilament intensity was
quantified separately. n = 4 animals from 4 litters. Scale bar = 40 µm.
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Table 4.2: (Additional File 3) Table providing a description of the parameters used in gait
assessment.
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Table 4.3: (Additional File 4) Table providing additional measurements of gait in PAE and
control animals.
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5. Discussion
5.1 Summary of Major Findings
The research described in this dissertation investigated several aspects of
neuroimmune system activation following PAE. Many of the results were
unexpected, either contrasting with the originally stated hypotheses, or revealing
surprising discoveries that we had not originally sought to investigate.
Comparing the results of study #1 with those of study #2, provides
conclusive evidence that alcohol dose is the major determinant of neuroimmune
system activation. We confirmed that binge-like alcohol exposure results in
robust neuroinflammation. Importantly, we showed that just one day of exposure
to a high dose of alcohol results in dramatic increases in pro-inflammatory
cytokine production. Conversely, exposure to more moderate levels, over a
longer period of time, had little effect on neuroimmune system function or
activation.
We identified several other factors that can heavily influence the type of
neuroimmune response generated. Results from the study #1 showed differential
outcomes between males and females, indicating that neuroinflammation is
dependent on gender. Additionally, we found the neuroimmune response to be
highly brain-region specific, as findings from both study #1 and study #2 show
differences across brain regions. Most dramatic were the contrasting findings
between the hippocampus and cerebellum in study #2 after the binge exposure
paradigm (Figure 5.1). While the cerebellum showed robust neuronal loss and
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microglial activation, the hippocampus exhibited no signs of neuronal loss and
little change in microglial morphology. Furthermore, cytokine production was not
as pronounced in the hippocampus. Finally, comparing the results from study #2
with the literature indicates that the window of exposure is a major effector of
neuroinflammatiory outcomes. Our contrasting findings in the hippocampus and
cerebellum are likely explained by the limited window of exposure (P3-5), as
neuronal loss and neuroinflammation in the hippocampus have been observed
after windows of exposure encompassing slightly later time points (~P7-9)
42,208,213

. These findings further highlight the complex and dynamic nature of the

neuroimmune system.

Figure 5.1 Summary of Findings for Study #2.
The time course for production of pro-inflammatory cytokines, microglia and astrocyte activation,
and neuronal loss is shown relative to the exposure paradigm. All measurements are shown as
fold changes from air controls. Neonates were exposed to alcohol for 4 hrs daily on P3, P4, and
P5. Samples collected on P3 and P5 were at times of peak BAC (labeled BAC). Samples
collected on P4 and P6 were taken during withdrawal (labeled W.D.)
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As previously stated, we originally designed study #2 around the
hypothesis that there would be a polarization switch in neuroimmune activation
from M1 to M2 over the course of the binge-like exposure paradigm. While we
did not see evidence of this, there was a subtle, yet definitive increase in antiinflammatory cytokines that persisted throughout the exposure paradigm. This
indicates that there is a component of this response that is anti-inflammatory and
it likely influences the course of neuroinflammation and neuronal survival.
One of the most surprising findings was with respect to the impact of
withdrawal periods in study #2. We expected cytokine production to increase with
each day of alcohol exposure, however mRNA expression was most pronounced
during withdrawal periods and dropped off during peak BACs. Additionally, we
found that astrocyte activation was evident in both brain regions, occurring
independently of microglial activation and neuronal loss. Little has been done
previously to address astrocyte activation in a model of PAE, and astrocytes
have often been designated to play a more secondary role with respect to
microglia. However, these findings indicate that astrocytes may have an
important role in mediating PAE that is distinct from microglia. Specifically, the
fact that robust astrocyte activation occurred without corresponding neuronal loss
supports that idea that astrocytes likely do not play a neurotoxic role, and may
instead contribute to neuronal survival.
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5.2 Potential Mechanisms
5.2.1 Study #1
While in study #1 we did not expect to see the type of robust
neuroinflammation associated with acute binge exposures, it is surprising that
there was so little effect on neuroimmune function. The exposure paradigm used
in this study encompassed the full two postnatal weeks, a period in which the
majority of gliogenesis and glial cell maturation is thought to occur163,169. The
evidence for microglial maturation during the first two weeks of life is based
primarily on the well-characterized changes in microglial morphology. This
structural transition consists of amoeboid microglia adopting the small cell body
and long dendritic processes associated with a ramified morphology, and take
place during the first two weeks of postnatal life163. A similar transition occurs in
the human brain, in which fully ramified microglia are not evident until close to
term (35 weeks)303. However, the phenotypic changes that occur during
microglial maturation, including expression of the multitude of receptors exhibited
by microglia in the adult brain, is not yet fully characterized. Several recent
studies have begun to investigate this process.
In an elegant study by Butovsky and colleagues, microglia were shown to
have a distinct genetic and proteomic profile. This signature consists of hundreds
of genes and proteins that distinguish them from other neural and/or immune
cells, including macrophage, astrocytes, and oligodendrocytes. The authors then
demonstrated that this profile does not exist in microglia on P1 or P4. Moreover,
microglia at this young age had very little expression of any of the investigated
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microglial genes, including many for receptors (such as purinergic receptors),
transcription factors, and ion channels. Instead, the full genetic signature of a
mature microglia was adopted between P21 and 2 months of life304. These
findings indicate that microglia are not fully mature until ~ 2 months of age,
despite the fact that they adopt a mature morphology by P14 (Figure 5.2).
Similarly, a study by Crain and colleagues showed that the expression of
purinergic receptors in microglia is highly dependent on age. Assessing multiple
ages, they showed evidence that also suggests microglia do not display a mature
receptor profile until several months post birth. Interestingly, certain purinergic
receptor types were expressed preferentially at a very young age (P3), compared
to more mature microglia305.

Figure 5.2: Glial Cell Maturation
The approximate time course for morphological and molecules maturation rates of astrocytes and
microglia are shown relative to the moderate PAE paradigm used in study #1.
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Considering these two studies, it is possible that moderate alcohol
exposure during the postnatal period does not readily activate microglia, as they
are still too immature. If the expression of the receptors and other proteins
necessary for microglial activation is very low at this age, then perhaps microglia
are much less sensitive to insult and a larger dose of alcohol is necessary to
evoke a response. For example, ATP is a strong regulator of microglial activity,
capable of causing rapid migration and cytokine production, and is released by
glial cells and neurons306. ATP binds to purinergic receptors; many of the
purinergic receptor types that are expressed in mature microglia were among
those shown to be minimally expressed in young microglia304,305. Conversely,
there was a higher expression at this age of other purinergic receptor types not
seen heavily in adults305. It is possible that different receptors are expressed in
the postnatal period to help with developmental processes, such as proper
migration. Therefore, it is likely that neuroimmune signaling is impaired to some
extent in the postnatal period, or at least different from in a mature microglia.
The process of microglial maturation has been shown to be dependent on
a number of factors. In the Butovsky study, adoption of the mature microglial
genetic profile was dependent on TGFβ signaling. Conversely, research by
Zusso and colleagues showed that microglial morphological maturation requires
the transcription factor Runx1. Runx1 is highly expressed in microglia during the
embryonic and early postnatal stages, however it is down-regulated as microglia
progress to a ramified form. The authors demonstrated that Runx1 blocks the
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proliferation of amoeboid microglia and promotes progression to ramification.
Furthermore, in the adult brain Runx1 was found to inhibit microglial activation,
and its expression increases with activation, potentially acting as an automatic
brake system. The authors speculate that Runx1 may act similarly in immature
amoeboid microglia, preventing activation307. If this is the case, then the
increased Runx1 expression seen in the early postnatal stages may further
inhibit microglial activation by alcohol exposure at this age.
In addition to Runx1 and TGFβ, the transcription factors IRF-8 and PU.1,
as well as the microRNA miR124 and the tyrosine kinase transmembrane
receptor CSF1R, have all been implicated in the regulation of microglia or
monocyte maturation224. In humans, some of these same factors have been
shown to control important processes in human microglia, such as proliferation,
suggesting human microglial development may be similarly regulated308,309. Of
the factors listed above, to the extent of my knowledge, only PU.1 and miR124
have been demonstrated to be affected by alcohol, and only in adult
models310,311. While the affects seen in an adult model are often not reflective of
changes in a neonate, it is still somewhat surprising that neonatal alcohol
exposure did not alter neuroimmune programming in study #1. However,
changes in the expression of PU.1 in response to alcohol was investigated only
in the periphery, not the CNS, and the exposure model was chronic, as
compared to the acute exposure in study #2311. Similarly, the changes in mir124
were seen after a 10-day alcohol exposure model and only in the limbic
forebrain310. Therefore, findings from both of these studies are likely highly
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influenced by the longer duration of the exposure paradigms, the fact that these
were adults, and the specific regions in which expression was affected.
Furthermore, both study #2 and previous studies in the literature212,213 have
shown that PAE can elevate TGFβ expression, which the Butovsky study showed
regulates the adoption of a mature genetic and proteomic profile in microglia.
However, in that study, the authors only showed that this process was impaired
in TGFβ deficient animals, and it is unclear what the effect would be, if any, from
elevated expression.
As for astrocytes, they too undergo pronounced morphological changes
and gliogenesis during the postnatal period. Again, this is reflective of what has
been reported to occur in the human brain312. Similar to microglia, the molecular
maturation of astrocytes occurs after their morphological development169 (Figure
5.2). Astrocytes begin expressing several genes important to their mature
function, including the glutamate transporter GLT1, proteins involved in astrocytic
gap junctions, and potassium channels, at around 3-4 weeks of age. Therefore,
there is a low expression of these genes during the postnatal period, which
further suggests that neuroimmune signaling is impaired during this time.
Particularly important is the loss of gap junction proteins, as much of astrocytic
signaling is thought to occur across this network. On the other hand, GLT1 is
critical for the proper clearance of glutamate from neuronal synapses, suggesting
that this function may be blunted in young astrocytes, and increasing the risk for
neuronal excitotoxicity169.
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Little is known about the process of priming and in what way a primed
neuroimmune cell differs from normal. However, up-regulation in microglial
surface receptors and an increase in number are associated with this change.
Additionally, particularly in cases of neurodegeneration, there can be a loss of
inhibitory signaling from neurons, making the microglia more easily activated313.
In a previous study showing neuroimmune system priming after a neonatal insult,
the initial infection induced a neuroinflammatory response, characterized by
increased cytokine production227. While expression of most cytokines was no
longer elevated in adulthood, there was an increase in the microglial activation
marker, CD11b227. This increase in CD11b could be a lingering result of
microglial activation by the neonatal infection. Therefore, it is possible that initial
neuroimmune activation is necessary to induce priming of these cells to future
insults. With the moderate PAE model used in study #1, we did not find any signs
of neuroimmune activation by alcohol exposure (Section A.1), and this may
explain why there was no exaggerated response to a subsequent injection of
LPS.
Compared to microglia, the role of astrocytes in neuroimmune system
programming has been much less explored. However, astrocytes have been
shown to become primed in neurodegenerative diseases, producing markedly
exaggerated increase in chemokines after stimulation with inflammatory
cytokines, which resulted in infiltration of peripheral immune cells314. Therefore,
this suggests that astrocytes may be an important component of neuroimmune
priming. Furthermore, astrocytes can exert powerful control over microglial
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activation, often times preventing it139. As a result, astrocytes could be
responding to moderate PAE by secreting factors that prevent microglial
activation. This represents an additional mechanism by which neuroimmune
system activation is blunted following moderate PAE.
Taken together, the possibility described above that the immature
neuroimmune system may be more difficult to activate than in adult and
adolescent rats, combined with the idea that neuroimmune activation is
necessary to induce priming, could explain why there are no changes in
neuroimmune system function following moderate PAE. Figure 5.3 summarizes
the potential mechanisms for study #1 described above.
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Figure 5.3 Summary of Potential Mechanisms for Study #1
Normal priming likely involves activation of the neuroimmune response during the postnatal
period (A). Peripheral insults, such as infections, cause inflammation throughout the body. These
increases in cytokines and other pro-inflammatory molecules can cross the BBB and distress
neurons, causing them to remove signaling that inhibits microglial activation, such as fractalkine,
and release other molecules that can activate microglia (ATP, glutamate). Immature microglia
likely express lower levels of certain receptors, however high concentrations of peripheral
cytokines or neurotransmitters can bind to the limited number of receptors and induce
transcription of genes involved in microglial activation. Activated microglia then produce cytokines
and up-regulate cell-surface receptors. In adulthood, CD11b remains up-regulated in primed
microglia and a subsequent insult by LPS leads to an over-production of inflammatory molecules
which can damage neurons.
In the moderate PAE model used in study #1 (B), the relatively low dose of alcohol may cause
some peripheral cytokine infiltration and minimal neuronal distress. However, the lower
concentration of signaling molecules, combined with the limited number of receptors are not
enough to overcome the inhibitory actions of Runx1 at this age. Microglial activation does not
occur, and therefore does not influence neuroimmune programming to subsequent insults.
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5.2.2 Study #2
One of the most puzzling findings of study #2 is the differential
susceptibility of the cerebellum and hippocampus to PAE. It is well-described that
different brain regions, and even the cells within these regions, have different
vulnerabilities and periods of increased susceptibility to developmental alcohol
exposure31,233. Likely this is due to the fact that the individual brain regions, and
cells within them, do not share the same maturation rates and timelines for
developmental processes.
In models of PAE, the cerebellum has continuously been shown to be the
most susceptible to damage, particularly neuronal loss, on P4-P570,72, while the
vulnerability of this region drops off later in the postnatal week. In an effort to
explain this phenomenon, a study by Heaton and colleagues investigated the
production of reactive oxygen species (ROS) in the cerebellum, after exposure to
alcohol at different developmental time points. Using vapor inhalation, the
authors exposed pups to alcohol on P4, P7, or P14. Exposure on P4 resulted in
rapid and dramatic increases in ROS, while exposure on P7 or P14 decreased
ROS expression315. ROS are extremely reactive molecules that are wellestablished as contributing to tissue damage and neuronal death316. In the CNS,
they can be secreted by activated microglia and astrocytes317,318, and under
conditions of excitotoxicity neurons have a markedly elevated production of
ROS319. Changes in ROS expression likely contributes to, or is a result of, the
increased neuronal death seen after alcohol exposure during the P4-5 time
window. Additionally, in another similarly designed study, Heaton and colleagues
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showed that exposure to alcohol on P4-5 was the only temporal window that
caused a decrease in nerve growth factor320. Nerve growth factor supports
Purkinje cells and increases neuronal survival321, and a decreased expression
could further explain this temporal susceptibility to neuronal loss.
In the hippocampus, alcohol exposure on P7 has repeatedly been shown
to cause neuronal damage/loss and affect neurogenesis42,322-324. However,
alcohol exposure on P4 does not cause neuronal loss in the hippocampus 44 and
causes the most pronounced neuronal loss in the cerebellum, compared to other
brain regions71. To the extent of my knowledge, little has been done to
investigate the mechanisms responsible for this developmentally-dependent
susceptibility of the hippocampus. However, one interesting study by Ikonomidou
and colleagues looked at the vulnerability of the developing brain to damage by
excitotoxicity. The authors injected the animals with N-methyl aspartate, which
activates glutamate receptors, on P4, P6, or P10 and performed analyses within
4 hours of injection. They found that the hippocampus was resistant to excitotoxic
damage after injection on P4 or P10, but that there was a significant increase in
neuronal death after injection on P6325. Indeed, excitotoxicity and alterations in
glutamate receptors have long been hypothesized as a potential mechanism for
mediating alcohol-induced damage in the developing brain326. Models of PAE
have shown increases in NMDA receptor subunits327,328 and decreased
GABAergic inhibition of some neurons329. Therefore, it is likely that the temporal
susceptibility to excitotoxicity in the hippocampus contributes to its similar
window of vulnerability to PAE-induced neuronal loss.
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In study #2, we found that it was during the periods of withdrawal that
cytokine expression was increased, and not during peak BACs. Interestingly,
withdrawal following PAE can cause excitotoxicity in the hippocampus and
cerebellum330,331, and in the cerebellum has been suggested to cause more
damage than the alcohol exposure itself
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. Furthermore, mitigation of alcohol

withdrawal periods in neonates rescues behavioral deficits associated with
impaired functioning of the hippocampus and the cerebellum279,332,333. Finally,
alcohol withdrawal has been implicated in neuroimmune activation, as it
increases the number of microglia280 and the density of astrocytes334 in the adult
brain. Taken together, it is possible that in study #2 alcohol withdrawal leads to
excitotoxic neurons and neuroimmune activation.
In support of this, as mentioned above, the hippocampus is resistant to
excitotoxic insult during the period of the exposure paradigm utilized in study #2,
which would explain why this region is much less affected. Additionally, in the
studies by Heaton and colleagues discussed above, PAE on P4 increased ROS
production in the cerebellum, which is strongly associated with excitotoxic
neurons. Therefore, the ROS production they observed could be due, in part, to
PAE-induced excitotoxicity. Furthermore, as previously discussed, astrocytes at
this age are still molecularly immature and do not fully express GLT1. GLT1 is
important for astrocyte removal of glutamate from neuronal synapses, thereby
preventing excitotoxicity. Therefore, neurons may be particularly at risk for
excitotoxic insult during this time. Under this theory, withdrawal periods could

136

directly cause neuronal damage and/or loss in the cerebellum through
excitotoxicity.
Neuronal distress can activate microglia, causing increased cytokine
production. A potential mechanism for neuronal activation of microglia, following
alcohol exposure, was shown in a recent study by Zou and Crews. The authors
demonstrated that, in adults, neurons release HMGB1 in response to alcohol,
and that HMGB1 then activates microglia by binding to TLR4. Importantly,
HMGB1 can be released from dying neurons189. Therefore, HMGB1 release by
damaged neurons represents an additional mechanism for microglial activation
during withdrawal periods of PAE. Microglial activation could then further
contribute to neuronal loss through increased pro-inflammatory cytokine
production.
Given the massive neuronal death seen in study #2, it is odd that there is
such little presence of microglia within the Purkinje cell layer. In both the air
control and PAE cerebellar sections, microglia are located centrally within the
lobules, in the places that contain the deep white matter in an adult vermis.
Based on this, we hypothesized that microglia may be centered on Purkinje cell
axonal tracts, however staining for PanNeuronal and myelin binding protein
showed no evidence of this type of patterning (Section A.4). Additionally, the
white matter seems to be only beginning to be formed by P6 (Section A.4, Figure
4.12). Instead, it seems that this PAE paradigm does not induce chemotaxis in
microglia. This contrasts with the idea of excitotoxic neurons, as microglia should
be phagocytosing dying neurons, and excess glutamate has been shown to
137

induce chemotaxis in microglia335. However, it is possible that microglia are slow
to respond given their immaturity and the fact that they do not fully express some
of the receptors necessary for neuroinflammatory chemotaxis. As discussed
above, the Butovsky and Crain studies show that microglia in the postnatal
period have different receptor expression than in mature microglia, including
receptors such as purinergic receptors, which are critical for mediating
chemotaxis toward insults304,305. Additionally, TGFβ has been shown to inhibit
microglial chemotaxis336, and in study #2 we found that alcohol caused a
significant, prolonged increase in TGFβ mRNA expression.
Another puzzling result of study #2, pertains to the unique neuroimmune
response of astrocytes. Astrocytes are closely organized around neuronal
synapses where they normally remove excess glutamate and also help to
combat the production of ROS by releasing the antioxidant glutathione (GSH)337.
In times of excitotoxicity, astrocytes can respond by increasing GLT1 expression
to promote glutamate up-take338, and in neurodegenerative diseases they can
become a structural replacement for dying neurons and promote neuronal
survival339. Therefore, these important roles of astrocytes may mean that
astrocytes are quicker to respond to neuronal insult following PAE, and may
provide insight into their unique role.
A study by Douhou and colleagues found strikingly similar results to study
#2, concerning the relationship between astrocytes, microglia, and neuronal loss
during a developmental time period. In this study, the authors used a mouse
model of Parkinson’s disease, in which Dopaminergic cell loss begins to occur
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around P15. They observed a rapid increase in GFAP expression at this time,
including in regions in which neuronal loss was not found. Moreover, they found
that areas with the highest increases in GFAP expression correlated with the
best neuronal survival. Furthermore, the authors described an increase in
microglial activation that was delayed compared to astrocytes and coincided only
with the peak of neuronal loss340. This is very similar to the results of study #2, in
which astrocyte activation occurs in both the hippocampus and cerebellum,
regardless of neuronal loss, and astrocyte activation seems to precede microglial
activation. Furthermore, in study #2, microglial activation was only observed in
the brain region in which neuronal loss occurred.
Douhou and colleagues speculated that, in their model, astrocyte
activation served as a support mechanism for distressed neurons, and that
astrocyte activation in areas without neuronal loss was a preventative measure.
Additionally, microglial activation seemed to be secondary to neuronal loss, likely
to remove neuronal debris340. Therefore, it is possible that neurons in the
hippocampus could still be experiencing distress from this high dose PAE
paradigm that, while much less in comparison to the cerebellum, still activates
astrocytes to provide neuronal support. In the hippocampus astrocyte activation
could be enough to rescue any neuronal damage, and if microglia are activated
secondarily only to neuronal death, then this would explain why little
morphological activation is seen in the hippocampus.
The potential mechanisms described in this section are summarized in
Figure 5.4. Importantly, in this mechanism, neuronal death is initially caused by
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excitotoxicity, with only a partial contribution by microglia. Conversely, astrocyte
activation is critical for neuronal support and survival, and there is a distinct
possibility that there is some M2 microglial activation that contributes to the antiinflammatory

cytokine

response.

Therefore,

according

to

neuroimmune activation has opposing roles in neuronal damage.
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this

model,

Figure 5.4 Summary of Possible Mechanisms for Study #2.
In the cerebellum (A) exposure to alcohol and particularly alcohol withdrawal periods induces
excitotoxicity in Purkinje neurons, potentially through alterations in NMDA receptors (1).
Excitotoxicity results in rapid response by astrocytes (2) as they become reactive and up-regulate
glutamate transporter GLT1 (to remove excess glutamate), the antioxidant GSH (to combat ROS
production), and anti-inflammatory/neuroprotective cytokines. Excitotoxic neurons reduce
signaling of inhibitory molecules, such as fractalkine, which normally block microglial activation.
Excitotoxic neurons also release molecules such as HMGB1, ATP, and ROS, which can activate
microglia (3). Importantly, microglial chemotaxis is not induced by ATP as the correct purinergic
receptors are not yet expressed, and production of TGFβ also blunts chemotaxis. Activated
microglia produce pro-inflammatory IL1β, TNFα, and ROS which further contribute to neuronal
damage (4).
In the hippocampus (B), neurons are resistant to excitotoxic insult (1). However, withdrawal
following binge alcohol exposure still causes some neuronal distress, activating astrocytes (2).
Alternatively, astrocytes are activated by signaling from cerebellar astrocytes. The distressed
neurons reduce signaling of inhibitory fractalkine, leading to slight microglial activation and
production of TNFα (3). The immature microglia of the hippocampus do not become fully
activated without secretion of additional molecules, and therefore do not further damage neurons.
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5.3 Clinical Implications
Blunting of neuroimmune system activation has been proposed as a
potential therapeutic option for the treatment of FASDs. Several previous studies
have shown improved outcomes in neuronal survival and behavioral tasks after
PAE if neuroinflammation is prevented209,210,212,213. However, the observations in
this dissertation indicate that treatment designed around this concept will need to
strongly consider each patient case individually, given the enormous number of
factors identified herein that can influence neuroinflammatory outcomes.
Importantly, therapeutics aimed at blocking neuroimmune system activation will
likely be ineffective in women who do not binge drink, although they may be
helpful in women who drink heavily on even one day of pregnancy.
While this work does not provide a conclusion on the relationship between
neuroinflammation and neuronal loss, it provides some additional evidence for
both sides of the argument. On one hand, microglial activation corresponded
heavily with neuronal loss. Conversely, microglia were rarely located within the
cell layer in which neurodegeneration occurred. However, if microglial activation
does contribute to neurotoxicity it is important to consider that agents designed to
block neuroimmune activation will likely also reduce the anti-inflammatory
component and astrocyte activity. This may block any beneficial effects that
TGFβ, IL10, or astrocytes may have in this case.
To sum, the neuroimmune system is a promising therapeutic target for
cases of binge-like exposure, however completely blocking neuroinflammation
may have some negative consequences. I suggest that a focus on shifting the
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polarization from M1 to M2, or mitigating withdrawal periods should also be
considered as a potential treatment option.

5.4 Critique
Both study #1 and study #2 utilized an exposure model in which the pups
inhaled vaporized alcohol rather than ingesting it. Despite the advantages of this
paradigm, it could be a potential confound in these studies, as the alcohol is not
metabolized by the stomach and liver upon first entering the body as it would be
if the alcohol was ingested orally.

Normally, alcohol is broken down by the

enzyme alcohol dehydrogenase, producing acetaldehyde, which is a reactive and
toxic metabolite10. However, alcohol can be metabolized by other tissues, such
as the brain10. Additionally, the alcohol now enters the bloodstream through the
lungs, where the high dose likely causes inflammation and potentially damages
the tissue. This peripheral inflammation could contribute to, or influence the
neuroimmune response, as these systems are highly communicative and
influential with each other76. Additionally, the exposure model in study #2 elicited
very high BACs. While this was done intentionally, in part because rodents may
be less sensitive to alcohol16, this still represents an additional confound as it
may not represent physiologically relevant BACs. Furthermore, the high levels of
alcohol vapor within the chambers likely introduce an element of stress to the
pups, as the smell is very potent and aversive. There is a strong relationship
between stress and the neuroimmune system341,342, and FAE can exacerbate
stress responses343,344. Either of these relationships could potentially influence
outcomes and should be taken into account when considering the results of this
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study. Finally, while nursing and maternal care were not found to be significantly
affected in study #2, there were still indications (trends) that these may be slightly
altered in the PAE animals. Both maternal care and nutrition can affect the
neuroimmune system345,346, and should continue to be carefully monitored in
future studies.
In study #2, glial cell morphology was used as the main determinant of
activation. While morphological transition is considered strongly indicative of
activation, this is not always the case and, importantly, does not provide a
complete picture of phenotype. As a result, it is difficult to determine how the glial
cells are responding to PAE and what their actions are. Additionally, while IBA-1
was used to label microglia, this marker labels monocytes and monocyte-derived
cells. Since microglia and macrophage are both monocyte-derived, this stain
cannot differentiate between the two. By immunohistochemistry, macrophages
appear similar to amoeboid microglia, therefore it is possible that the microglia
labeled as being in an amoeboid morphology are actually peripheral
macrophages. Furthermore, no assessment of peripheral immune cells was
included in this study. As a result, we cannot discount the possibility that
infiltrating cells are contributing to increased cytokine production and potentially
neuronal loss.
In both study #1 and study #2, cytokine production is assessed by
measuring mRNA. While perfusions were performed before collecting samples
for immunohistochemistry, brains were not perfused before collection of samples
for mRNA. As a result, the blood vessel network within the collected tissue
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sample likely contains circulating cytokines that are not actually within the CNS
parenchyma, potentially biasing the results. Additionally, for study #2 we
confirmed that IL1β protein expression mimics what occurs at the level of mRNA
on P4 in both the hippocampus and cerebellum (Section A.2, Figure A.2.1).
However, protein expression was not measured along the full time course, and
no other cytokines were included. Therefore, we cannot definitively say that the
changes observed in mRNA are reflective of what occurs at the level of protein.
Moreover, even if cytokine mRNA is translated into protein, we do not know that
it is being processed into the activated form. Furthermore, while there exist
hundreds of different cytokines, we have only included four in this study as it
would have been unrealistic to assess all of them. As a result, there could be
important actions by, or changes in the levels of, other cytokines that we are
unaware of. Finally, we have made assumptions about the pro- and antiinflammatory actions of the cytokines measured, yet, as detailed in the
introduction, activation of these cytokine signaling pathways can have a number
of different outcomes. Therefore it is impossible to say for sure what their exact
actions are and, because both glial cells and neurons express many of these
receptors, upon which cells they are acting.
For study #1 and study #2, we used ketamine to humanely anesthetize the
pups before euthanizing them. Since ketamine has been shown to cause
neuronal apoptosis, using this drug could confound the results in this study347,348.
While, this is unlikely as typically prolonged exposure to ketamine is needed to
cause neuronal loss, any type of insult to neurons can potentially elicit a
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neuroimmune response. Additionally, ketamine has also been shown to have
some effects on microglia349,350. Therefore, this should be considered when
interpreting results.
Finally, while study #2 provided new information critical to understanding
neuroimmune system activation following PAE, it does not include an
investigation into the mechanism of how alcohol is activating the neuroimmune
system at this age. It is still unclear whether or not neuroinflammation contributes
to neuronal loss. Future work should expand on these findings and address
these lingering questions.

5.5 Future Directions
There are a number of different experiments that could be done to follow
up on this work. One of the most pertinent would be to investigate more the
individual roles of the neuroimmune cells in the binge exposure paradigm. To
discover what cytokine expression is due to astrocytes and what is produced by
microglia, the cells could be isolated and assessed by flow cytometry.
Extracellular markers can be used for GFAP to label astrocytes, and CD11b to
label microglia. Then, intracellular markers could be used for expression of
cytokines. Additionally, co-staining for CD11b and CD45 will allow for
identification of any infiltrating macrophage that could not be distinguished from
microglia by immunohistochemistry. Specifically, both microglia and macrophage
express CD11b, but microglial expression of CD45 is low, while macrophages
more highly express CD45351. To more thoroughly investigate contributions by
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peripheral immune cells, additional IHC could be performed for lymphocytes
(such as T cells and B cells) and leukocytes. Furthermore, it would be interesting
to see if this paradigm increases BBB permeability given the dramatic increases
in pro-inflammatory cytokines. There are a number of assays that can be used to
assess BBB breakdown. One of the simplest assessments involves injecting a
fluorescent dye, such as fluorescein, that does not cross the BBB under normal
conditions. If the dye is found in the brain, this indicates that the BBB is no longer
tightly sealed.
Another future experiment would be to investigate the mechanism for how
alcohol activates the neuroimmune system. As described in the introduction
section, in adults there is evidence that activation of microglia by alcohol is
dependent on toll-like receptors, particularly TLR4185,189. Furthermore, activation
of TLR4 has been shown to be caused by primarily neuronal secretion of the
cytokine HMGB1189. It would be interesting to see if this is also the case in FAE.
To start, TLR4 knockout animals could be exposed to the binge alcohol exposure
paradigm used for study #2, and neuroinflammation could again be assessed. If
the TLR4 knockout animals have diminished neuroinflammation, the effect this
has on neuronal loss could also be investigated. Additionally, increased levels of
HMGB1 could be assessed by measuring protein levels. If the proposed
mechanism for alcohol in adult animals is relevant to neonates, then HMGB1
expression should be increased in PAE animals.
To follow-up on the differences seen in the hippocampus and cerebellum
in study #2, it would be interesting to perform this study again using a different
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window of exposure. Specifically, exposing neonates to the same dose of alcohol
used in this study, again over a 3-day period, however this time utilizing a
window shown to cause neuronal loss in the hippocampus (P7-9). I would expect
that the results would be flipped from what was seen in this study, with the
hippocampus having more neuronal loss than the cerebellum. Whether or not
neuroimmune activation is also increased in the hippocampus could shed more
light on the relationship between neuronal loss and neuroinflammation.
Additionally, while many studies have begun to investigate the use of
agents that prevent neuroimmune activation in PAE, the observations in this
study point to a potent effect of withdrawal periods. As a result, mitigating the
effects of withdrawal and assessing how this changes the neuroimmune
activation and neuronal loss seen after PAE could yield important insights. There
are a number of clinically approved drugs to treat alcohol withdrawal symptoms,
and if my findings are correct, I would expect that these drugs could reduce proinflammatory cytokine production, and potentially glial cell activation as a result.
In particular, more investigation should be conducted into the potential role
excitotoxicity during PAE and during withdrawal. Since NMDA receptors are often
implicated in excitotoxic mechanisms, perhaps NMDA receptor antagonists could
potentially represent an additional treatment option for prevention of FAS.
Finally, I think it would be important to confirm these findings in both other
models of exposure, and in females. As mentioned above, this vapor inhalation
has a number of potential confounds, as do most exposure paradigms, and so it
is important to confirm findings in the FAE field in multiple models. Alcohol could
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be administered by gavage, and some of the most pertinent findings of the binge
study could be repeated, such as the elevated cytokine levels on P4 and the drop
off on P5, and measurements of glial cell activation and neuronal loss on P6.
Additionally, as I found in study #2, gender influences neuroimmune outcomes.
Therefore, the experiments of study #2 should be repeated in females, and the
results should be compared. I expect that there could be vast differences
between the two groups, given the sexually dimorphic effects of alcohol
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and the differences in the neuroimmune system between males and females at
this age132,164.
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Appendix A: Supplemental Data

A.1 Investigation of basal effects of moderate PAE on neuroimmune
activation.
Purpose:
Before performing study #1, in which pups received LPS injections
following moderate PAE, we sought to test whether or not the moderate PAE
paradigm itself caused any neuroimmune changes. Specifically, we focused on
the dentate gyrus as this region has been shown to be particularly susceptible to
FAE32,230,231. This experiment was designed to be a general screening for any
changes in neuroinflammatory gene expression following this exposure.

Methods:
Ethanol treatment and collection of samples
Pups were exposed to alcohol via vapor inhalation for four hours daily, as
described in study #1. Moderate BACs were achieved from P2 through P16. On
P17, the dentate gyrus was isolated and harvested for mRNA as described in
study #1. For protein extraction, dentates were placed into ice cold
homogenization buffer (25 mM HEPES, 500 mM NaCl, 2 mM EDTA, 1 mM DTT,
10% Tween 20, 1 mM phenylmethanesulfonyl fluoride, 20 mM NaF, 5 µM
Cyclosporin A, 1% v/v phosphatase inhibitor cocktail [Sigma, Cat. No. P2850],
and 1 complete Mini Protease tablet [Roche]), homogenized, and stored in
aliquots at -80°C. Both males and females were used.

150

PCR Arrays and Validation
Gene expression was initially measured using a quantitative real-time
PCR

array

focusing

on

rat

inflammatory

cytokines

and

receptors

(SABiosciences/Qiagen, Cat No. PARN-011Z) in combination with the RT2 SYBR
Green qPCR Master Mix (SABiosciences/Qiagen). Additional quantitative realtime PCR was conducted to validate any significant findings of the array. For
validation of array findings, primers were identical to those on the array and were
purchased from SABiosciences/Qiagen including Cd40lg (Cat. No. PPR49715A),
Ccl5 (Cat. No. PPR06854F), Il11 (Cat. No. PPR06463F), and HPRT1 (Cat. No.
PPR42247F). RT-PCR was carried out as described in study #1.
Western blotting
After homogenization by sonication the dentate gyri from 2 pups in each
litter were pooled, tissues were frozen and stored at -80 °C until use. Protein was
quantified using a Bio-rad protein assay (Cat. No. 500-0006). Samples were
mixed with a 5X SDS-PAGE sample buffer containing 250 mM Tris–HCl (pH 6.8),
10% sodium dodecyl sulfate, 30% glycerol, 5% β-mercaptoethanol, and 0.02%
bromophenol blue, and boiled for 5 min. Final concentration of protein
homogenates was 1 mg/mL and each sample was loaded as 5, 10, and 15
µg/lane. The proteins were separated in 4-15% Tris-HCl precast gels (BioRad) at
110 V for 70 min, then transferred to a polyvinylidene fluoride (0.45 µm) at 100 V
for 70 min. After, blots were incubated in blocking buffer (LI-COR, Lincoln, NE)
for 2 hours, and then allowed to sit overnight at 4 °C in 1X phosphate buffered
saline with 0.1% Tween 20 containing a rabbit polyclonal IL-11 antibody (1:1000,
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Santa Cruz Biotechnology,sc-7924) and a monoclonal mouse β-actin antibody
(1:25,000, Sigma). Secondary antibodies were Goat anti-mouse (LI-COR, IRDye
680) and Goat anti-rabbit (LI-COR, IRDYE 800CW). Blots were developed using
an Odyssey infrared imager (LI-COR) and quantified with Odyssey V3.0 software
(LI-COR) using integrated intensity. All primary antibodies used were found to fall
within the linear dynamic range (data not shown) at this dilution and with this
quantification method.
ELISA
Protein samples were centrifuged at 8 X 103 g for 10 minutes at 4°C. The
supernatants were transferred to a fresh tube, aliquoted, and stored at -80°C until
use. Protein was quantified using a Bio-rad protein assay (Cat. No. 500-0006).
Samples were normalized to the one containing the lowest concentration of
protein and an ELISA measuring CCL5 was run according to the manufacturer’s
instructions (R&D systems, Cat. No. MMR00)

Results:
The arrays revealed no significant changes in gene expression in female
pups (Table A.1.2), however the array showed three genes were significantly
altered in males (Table A.1.1). CD40l (CD40 ligand, important for activation of T
cells) and CCL5 (chemokine C-C motif ligand 5, pro-inflammatory chemokine)
were significantly up-regulated by moderate PAE, while the anti-inflammatory
cytokine IL11 (interleukin-11) was significantly down-regulated. However, PCR
validation was unable to confirm the findings of the array for any of these genes
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(Figure A.1.1, A-C). Similarly, IL-11 and CCL5 were tested for changes in protein
levels, and these were also found to be unaffected by moderate PAE (Figure
A.1.1, D-F).

Table A.1.1 Inflammatory Gene Expression in Males after Postnatal Alcohol Exposure

mRNA isolated from the dentate gyrus of male pups was run on an inflammatory gene
array containing 84 different genes. This table shows the genes most affected by
moderate PAE. n = 4 litters
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Figure A.1.1: Effect of moderate PAE on the Dentate Gyrus of Male Pups.
PCR validation shows that moderate PAE does not affect expression of CD40lg (A, n =4 litters),
CCL5 (B, n = 6-7 litters), or Il11 (C, n = 6-7 litters) at the level of mRNA. Protein levels of IL-11
are not affected by moderate PAE, as measured by western blot (D, E, n = 7 litters). An example
western blot for IL-11 is shown in (D) in which each sample was loaded in 5, 10, and 15 µg
protein concentrations and normalized to β-actin. Protein levels of CCL5 were unaffected by
moderate PAE, as measured by ELISA (F, n = 4 litters).
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Table A.1.2 Inflammatory Gene Expression in Females after Postnatal Alcohol Exposure

mRNA isolated from the dentate gyrus of female pups was run on an inflammatory gene
array containing 84 different genes. This table shows the genes most affected by
moderate PAE. n = 5-6 litters

Conclusions:
These data support the idea that moderate PAE has little effect on
neuroimmune system activation.
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A.2 Binge alcohol exposure increases IL1β protein expression on P4 in the
cerebellar vermis
Purpose:
This experiment was designed to test whether or not the changes in IL1β
mRNA after binge alcohol exposure translated to the level of protein.

Methods:
Pups were exposed to alcohol and sacrificed as described in study #2. On
P4, hippocampi and cerebellar vermis were removed and sonicated in ice cold
homogenization buffer containing 20 mM Tris, 0.25 M sucrose, 2 mM EDTA, 10
mM EGTA, 1% Triton x-100, and 1 SIGMAFAST Protease Inhibitor tablet.
Samples were centrifuged for 40 min at 100,000 X g and the supernatant was
collected and kept at -80 until use. Protein was quantified using a Bio-rad protein
assay (Cat. No. 500-0006). Levels of IL1β protein expression were quantified
using a Rat IL-1β/IL-1F2 Quantikine ELISA (R&D Systems, RLB00) according to
the manufacturer’s instructions. Statistics were determined by unpaired t-test.

Results:
IL1β expression on P4 was significantly increased by PAE in the
cerebellum to a similar extent as was seen in mRNA in study #2. In the
hippocampus, no increase was seen in IL1β protein on P4, which again
replicates the findings in mRNA in study #2.
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Figure A.2.1: Protein Expression of IL1β Following Binge Alcohol Exposure was Measured
on P4 in the Hippocampus and Cerebellum by ELISA.
Protein levels for the air control were averaged and then each individual data point for both air
control and PAE samples was normalized to this average. n = 4 litters. (* p < 0.05).

Conclusions:
These results show that on P4, the results seen in IL1β mRNA are closely
mirrored by expression at the level of protein.
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A.3 Binge alcohol exposure does not increase TUNEL staining in the
cerebellum on P4.
Purpose:
The purpose of this experiment was to see if signs of neuronal apoptosis
were already evident at P4, before neuronal loss occurred but concurrent with
increased cytokine production. Terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL) can be used to detect DNA fragmentation associated with
late-stage apoptosis in cells.

Methods:
Pups

were

exposed

to

alcohol,

sacrificed,

and

slices

for

immunohistochemistry were collected on P4, as described in study #2. To label
neurons undergoing apoptosis, TUNEL staining was performed using the TACS
2 TdT-Fluor In Situ Apoptosis Detection Kit (Trevigen, cat no. 4812-30-K,
Gaithersburg, MD), according to the manufacturer’s instructions. Slices were
imaged as described in study #2, and an analysis of TUNEL intensity was
completed in the external granule layer, the Purkinje layer, and the internal
granule layer.

Results:
In both air control and PAE animals, there were pockets of intense TUNEL
staining within the cerebellar vermis (Figure A.3.1a). No difference was observed
between the air control and PAE and there staining intensities were not elevated
in the Purkinje cell layer compared to the other layers (Figure A.3.1b).
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Figure A.3.1: Binge Alcohol Exposure does not Increase TUNEL Staining Intensity at P4 in
the Cerebellum.
Cerebellar sections were stained for TUNEL (red) to label cells undergoing apoptosis, and DAPI
(blue) to label cell nuclei. Example 10X images for PAE and air controls are shown (A). The
TUNEL staining intensity is quantified for the external granule layer, purkinje cell layer, and
internal granule layer (B). (n = 3-4 litters)

Conclusions:
TUNEL is a late marker for apoptosis, so there may be no increase in the
PAE animals at this age because cytokine production is only just spiking and
apoptosis is just beginning to occur. It is possible that TUNEL is most elevated
around P5, before neuronal loss is evident. Additionally, the pockets of intense
TUNEL staining in both groups is likely due to the period of programmed cell
death that occurs around this time 352.
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A.4 Microglia are not organized around neuronal axons at P6 in the
cerebellum
Purpose:
Staining for microglia in the postnatal cerebellum indicated that microglia
were not organized in the Purkinje cell layer, where neuronal death occurred.
Instead they were located centrally within the cerebellum and cerebellar lobules,
in the places that white matter would normally reside in an adult brain. We
hypothesized that microglia might be interacting with neuronal axons. To test
this, we stained for PanNeuronal, which is an antibody blend for multiple different
proteins expressed throughout neurons including in neuronal axons, and myelin
binding protein (MBP) which labels myelinated axons.
Methods:
Pups

were

exposed

to

alcohol,

sacrificed,

and

slices

for

immunohistochemistry were collected on P6, as described in study #2. The
following antibodies were used: rabbit anti-MBP (1:500, abcam, cat# ab40390
Cambridge, MA) and mouse anti-PanNeuronal (1:500, Millipore, cat# MAB2300,
Darmstadt, Germany). The immunohistochemistry protocol and secondary
antibodies are described in study #2. Images were taken and assembled such
that the entire cerebellar vermis section was visible and compared to similar
sections (used in study #2) from the same brain in which IBA-1 was used to label
microglia.
Results:
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MBP staining was barely visible within the cerebellar vermis at P6 in either
air controls or PAE pups. PanNeuronal staining was evident within the center of
the cerebellar vermis and was beginning to intensify within some lobules. No
differences were seen between air control and PAE animals. Additionally,
comparison of staining for microglia revealed no evidence of patterning in areas
in which PanNeuronal was seen.

Figure A.4.1
Representative images are shown from two PAE pups from separate litters. Staining for IBA-1
(microglia, red) and PanNeuronal (green) are shown in consecutive sections. Air controls had
similar PanNeuronal staining to these PAE animals.

161

Conclusions:
Neuronal axons are not myelinated within the cerebellar vermis at P6.
Additionally, little PanNeuronal staining is evident within the lobules at P6,
indicating that the axons are only beginning to extend outward from their cell
layers. The centralized organization of microglia does not seem to be in a
response to neuronal axons, however the massive number of amoeboid
microglia after PAE is evident throughout the cerebellar vermis.
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